1887

Abstract

The interferon (IFN) system is an extremely powerful antiviral response that is capable of controlling most, if not all, virus infections in the absence of adaptive immunity. However, viruses can still replicate and cause disease , because they have some strategy for at least partially circumventing the IFN response. We reviewed this topic in 2000 [Goodbourn, S., Didcock, L. & Randall, R. E. (2000). , 2341–2364] but, since then, a great deal has been discovered about the molecular mechanisms of the IFN response and how different viruses circumvent it. This information is of fundamental interest, but may also have practical application in the design and manufacture of attenuated virus vaccines and the development of novel antiviral drugs. In the first part of this review, we describe how viruses activate the IFN system, how IFNs induce transcription of their target genes and the mechanism of action of IFN-induced proteins with antiviral action. In the second part, we describe how viruses circumvent the IFN response. Here, we reflect upon possible consequences for both the virus and host of the different strategies that viruses have evolved and discuss whether certain viruses have exploited the IFN response to modulate their life cycle (e.g. to establish and maintain persistent/latent infections), whether perturbation of the IFN response by persistent infections can lead to chronic disease, and the importance of the IFN system as a species barrier to virus infections. Lastly, we briefly describe applied aspects that arise from an increase in our knowledge in this area, including vaccine design and manufacture, the development of novel antiviral drugs and the use of IFN-sensitive oncolytic viruses in the treatment of cancer.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83391-0
2008-01-01
2019-11-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/1/1.html?itemId=/content/journal/jgv/10.1099/vir.0.83391-0&mimeType=html&fmt=ahah

References

  1. Aguilar, P. V., Weaver, S. C. & Basler, C. F. ( 2007; ). Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J Virol 81, 3866–3876.[CrossRef]
    [Google Scholar]
  2. Ahmed, M. & Lyles, D. S. ( 1998; ). Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. J Virol 72, 8413–8419.
    [Google Scholar]
  3. Ahmed, M., McKenzie, M. O., Puckett, S., Hojnacki, M., Poliquin, L. & Lyles, D. S. ( 2003; ). Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol 77, 4646–4657.[CrossRef]
    [Google Scholar]
  4. Ahn, J. H. & Hayward, G. S. ( 2000; ). Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274, 39–55.[CrossRef]
    [Google Scholar]
  5. Alcami, A. & Smith, G. L. ( 1995; ). Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69, 4633–4639.
    [Google Scholar]
  6. Alcami, A., Symons, J. A. & Smith, G. L. ( 2000; ). The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 74, 11230–11239.[CrossRef]
    [Google Scholar]
  7. Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. ( 2001; ). Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732–738.[CrossRef]
    [Google Scholar]
  8. Alff, P. J., Gavrilovskaya, I. N., Gorbunova, E., Endriss, K., Chong, Y., Geimonen, E., Sen, N., Reich, N. C. & Mackow, E. R. ( 2006; ). The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80, 9676–9686.[CrossRef]
    [Google Scholar]
  9. Andrejeva, J., Young, D. F., Goodbourn, S. & Randall, R. E. ( 2002a; ). Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J Virol 76, 2159–2167.[CrossRef]
    [Google Scholar]
  10. Andrejeva, J., Poole, E., Young, D. F., Goodbourn, S. & Randall, R. E. ( 2002b; ). The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J Virol 76, 11379–11386.[CrossRef]
    [Google Scholar]
  11. Andrejeva, J., Childs, K. S., Young, D. F., Carlos, T. S., Stock, N., Goodbourn, S. & Randall, R. E. ( 2004; ). The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc Natl Acad Sci U S A 101, 17264–17269.[CrossRef]
    [Google Scholar]
  12. Ank, N., West, H. & Paludan, S. R. ( 2006; ). IFN-λ: novel antiviral cytokines. J Interferon Cytokine Res 26, 373–379.[CrossRef]
    [Google Scholar]
  13. Ankel, H., Westra, D. F., Welling-Wester, S. & Lebon, P. ( 1998; ). Induction of interferon-α by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 251, 317–326.[CrossRef]
    [Google Scholar]
  14. Antonsson, A., Payne, E., Hengst, K. & McMillan, N. A. ( 2006; ). The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation. J Interferon Cytokine Res 26, 455–461.[CrossRef]
    [Google Scholar]
  15. Argyris, E. G., Acheampong, E., Wang, F., Huang, J., Chen, K., Mukhtar, M. & Zhang, H. ( 2007; ). The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system. Virology 367, 440–451.[CrossRef]
    [Google Scholar]
  16. Asaoka, K., Ikeda, K., Hishinuma, T., Horie-Inoue, K., Takeda, S. & Inoue, S. ( 2005; ). A retrovirus restriction factor TRIM5α is transcriptionally regulated by interferons. Biochem Biophys Res Commun 338, 1950–1956.[CrossRef]
    [Google Scholar]
  17. Asefa, B., Klarmann, K. D., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. & Keller, J. R. ( 2004; ). The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis 32, 155–167.[CrossRef]
    [Google Scholar]
  18. Au, W. C., Moore, P. A., LaFleur, D. W., Tombal, B. & Pitha, P. M. ( 1998; ). Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 273, 29210–29217.[CrossRef]
    [Google Scholar]
  19. Balachandran, S., Kim, C. N., Yeh, W. C., Mak, T. W., Bhalla, K. & Barber, G. N. ( 1998; ). Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J 17, 6888–6902.[CrossRef]
    [Google Scholar]
  20. Balachandran, S., Roberts, P. C., Brown, L. E., Truong, H., Pattnaik, A. K., Archer, D. R. & Barber, G. N. ( 2000a; ). Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13, 129–141.[CrossRef]
    [Google Scholar]
  21. Balachandran, S., Roberts, P. C., Kipperman, T., Bhalla, K. N., Compans, R. W., Archer, D. R. & Barber, G. N. ( 2000b; ). Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J Virol 74, 1513–1523.[CrossRef]
    [Google Scholar]
  22. Balachandran, S., Venkataraman, T., Fisher, P. B. & Barber, G. N. ( 2007; ). Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol 178, 2429–2439.[CrossRef]
    [Google Scholar]
  23. Banninger, G. & Reich, N. C. ( 2004; ). STAT2 nuclear trafficking. J Biol Chem 279, 39199–39206.[CrossRef]
    [Google Scholar]
  24. Barnard, P. & McMillan, N. A. ( 1999; ). The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-α. Virology 259, 305–313.[CrossRef]
    [Google Scholar]
  25. Barnard, P., Payne, E. & McMillan, N. A. ( 2000; ). The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-α. Virology 277, 411–419.[CrossRef]
    [Google Scholar]
  26. Barnes, B. J., Richards, J., Mancl, M., Hanash, S., Beretta, L. & Pitha, P. M. ( 2004; ). Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279, 45194–45207.[CrossRef]
    [Google Scholar]
  27. Barro, M. & Patton, J. T. ( 2007; ). Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J Virol 81, 4473–4481.[CrossRef]
    [Google Scholar]
  28. Bartlett, E. J., Amaro-Carambot, E., Surman, S. R., Collins, P. L., Murphy, B. R. & Skiadopoulos, M. H. ( 2006; ). Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates. Vaccine 24, 2674–2684.[CrossRef]
    [Google Scholar]
  29. Barton, E. S., White, D. W., Cathelyn, J. S., Brett-McClellan, K. A., Engle, M., Diamond, M. S., Miller, V. L. & Virgin, H. W., IV ( 2007; ). Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326–329.[CrossRef]
    [Google Scholar]
  30. Basle, M. F., Russell, W. C., Goswami, K. K., Rebel, A., Giraudon, P., Wild, F. & Filmon, R. ( 1985; ). Paramyxovirus antigens in osteoclasts from Paget's bone tissue detected by monoclonal antibodies. J Gen Virol 66, 2103–2110.[CrossRef]
    [Google Scholar]
  31. Basle, M. F., Fournier, J. G., Rozenblatt, S., Rebel, A. & Bouteille, M. ( 1986; ). Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol 67, 907–913.[CrossRef]
    [Google Scholar]
  32. Basle, M. F., Rebel, A., Fournier, J. G., Russell, W. C. & Malkani, K. ( 1987; ). On the trail of paramyxoviruses in Paget's disease of bone. Clin Orthop Relat Res 217, 9–15.
    [Google Scholar]
  33. Bauhofer, O., Summerfield, A., McCullough, K. C. & Ruggli, N. ( 2005; ). Role of double-stranded RNA and Npro of classical swine fever virus in the activation of monocyte-derived dendritic cells. Virology 343, 93–105.[CrossRef]
    [Google Scholar]
  34. Bauhofer, O., Summerfield, A., Sakoda, Y., Tratschin, J. D., Hofmann, M. A. & Ruggli, N. ( 2007; ). Npro of classical swine fever virus interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J Virol 81, 3087–3096.[CrossRef]
    [Google Scholar]
  35. Baumert, T. F., Rosler, C., Malim, M. H. & von Weizsacker, F. ( 2007; ). Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 46, 682–689.
    [Google Scholar]
  36. Belov, G. A., Lidsky, P. V., Mikitas, O. V., Egger, D., Lukyanov, K. A., Bienz, K. & Agol, V. I. ( 2004; ). Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J Virol 78, 10166–10177.[CrossRef]
    [Google Scholar]
  37. Belsham, G. J., McInerney, G. M. & Ross-Smith, N. ( 2000; ). Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J Virol 74, 272–280.[CrossRef]
    [Google Scholar]
  38. Bender, I. B. ( 2003; ). Paget's disease. J Endod 29, 720–723.[CrossRef]
    [Google Scholar]
  39. Bergeron, J., Mabrouk, T., Garzon, S. & Lemay, G. ( 1998; ). Characterization of the thermosensitive ts453 reovirus mutant: increased dsRNA binding of ς3 protein correlates with interferon resistance. Virology 246, 199–210.[CrossRef]
    [Google Scholar]
  40. Berghall, H., Siren, J., Sarkar, D., Julkunen, I., Fisher, P. B., Vainionpaa, R. & Matikainen, S. ( 2006; ). The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines. Microbes Infect 8, 2138–2144.[CrossRef]
    [Google Scholar]
  41. Berkowitz, B., Huang, D. B., Chen-Park, F. E., Sigler, P. B. & Ghosh, G. ( 2002; ). The x-ray crystal structure of the NF-κB p50.p65 heterodimer bound to the interferon β- κ B site. J Biol Chem 277, 24694–24700.[CrossRef]
    [Google Scholar]
  42. Best, S. M., Morris, K. L., Shannon, J. G., Robertson, S. J., Mitzel, D. N., Park, G. S., Boer, E., Wolfinbarger, J. B. & Bloom, M. E. ( 2005; ). Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 79, 12828–12839.[CrossRef]
    [Google Scholar]
  43. Bhattacharya, S., Eckner, R., Grossman, S., Oldread, E., Arany, Z., D'Andrea, A. & Livingston, D. M. ( 1996; ). Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α. Nature 383, 344–347.[CrossRef]
    [Google Scholar]
  44. Billecocq, A., Spiegel, M., Vialat, P., Kohl, A., Weber, F., Bouloy, M. & Haller, O. ( 2004; ). NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78, 9798–9806.[CrossRef]
    [Google Scholar]
  45. Blakqori, G., Delhaye, S., Habjan, M., Blair, C. D., Sanchez-Vargas, I., Olson, K. E., Attarzadeh-Yazdi, G., Fragkoudis, R., Kohl, A. & other authors ( 2007; ). La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 81, 4991–4999.[CrossRef]
    [Google Scholar]
  46. Blindenbacher, A., Duong, F. H., Hunziker, L., Stutvoet, S. T., Wang, X., Terracciano, L., Moradpour, D., Blum, H. E., Alonzi, T. & other authors ( 2003; ). Expression of hepatitis c virus proteins inhibits interferon α signaling in the liver of transgenic mice. Gastroenterology 124, 1465–1475.[CrossRef]
    [Google Scholar]
  47. Blondel, D., Regad, T., Poisson, N., Pavie, B., Harper, F., Pandolfi, P. P., De The, H. & Chelbi-Alix, M. K. ( 2002; ). Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21, 7957–7970.[CrossRef]
    [Google Scholar]
  48. Bluyssen, H. A. & Levy, D. E. ( 1997; ). Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA. J Biol Chem 272, 4600–4605.[CrossRef]
    [Google Scholar]
  49. Bluyssen, H. A., Muzaffar, R., Vlieststra, R. J., van der Made, A. C., Leung, S., Stark, G. R., Kerr, I. M., Trapman, J. & Levy, D. E. ( 1995; ). Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci U S A 92, 5645–5649.[CrossRef]
    [Google Scholar]
  50. Bode, J. G., Ludwig, S., Ehrhardt, C., Albrecht, U., Erhardt, A., Schaper, F., Heinrich, P. C. & Haussinger, D. ( 2003; ). IFN-α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 17, 488–490.
    [Google Scholar]
  51. Boehme, K. W. & Compton, T. ( 2004; ). Innate sensing of viruses by Toll-like receptors. J Virol 78, 7867–7873.[CrossRef]
    [Google Scholar]
  52. Bolitho, P., Voskoboinik, I., Trapani, J. A. & Smyth, M. J. ( 2007; ). Apoptosis induced by the lymphocyte effector molecule perforin. Curr Opin Immunol 19, 339–347.[CrossRef]
    [Google Scholar]
  53. Bonvin, M., Achermann, F., Greeve, I., Stroka, D., Keogh, A., Inderbitzin, D., Candinas, D., Sommer, P., Wain-Hobson, S. & other authors ( 2006; ). Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43, 1364–1374.[CrossRef]
    [Google Scholar]
  54. Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R. C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S. & other authors ( 2004; ). The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5, 1052–1060.[CrossRef]
    [Google Scholar]
  55. Borden, K. L., Campbell Dwyer, E. J. & Salvato, M. S. ( 1998a; ). An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72, 758–766.
    [Google Scholar]
  56. Borden, K. L., Campbelldwyer, E. J., Carlile, G. W., Djavani, M. & Salvato, M. S. ( 1998b; ). Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol 72, 3819–3826.
    [Google Scholar]
  57. Bossert, B. & Conzelmann, K. K. ( 2002; ). Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J Virol 76, 4287–4293.[CrossRef]
    [Google Scholar]
  58. Bossert, B., Marozin, S. & Conzelmann, K. K. ( 2003; ). Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 77, 8661–8668.[CrossRef]
    [Google Scholar]
  59. Bouloy, M., Janzen, C., Vialat, P., Khun, H., Pavlovic, J., Huerre, M. & Haller, O. ( 2001; ). Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs. J Virol 75, 1371–1377.[CrossRef]
    [Google Scholar]
  60. Boyman, O., Purton, J. F., Surh, C. D. & Sprent, J. ( 2007; ). Cytokines and T-cell homeostasis. Curr Opin Immunol 19, 320–326.[CrossRef]
    [Google Scholar]
  61. Brideau-Andersen, A. D., Huang, X., Sun, S. C., Chen, T. T., Stark, D., Sas, I. J., Zadik, L., Dawes, G. N., Guptill, D. R. & other authors ( 2007; ). Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases. Proc Natl Acad Sci U S A 104, 8269–8274.[CrossRef]
    [Google Scholar]
  62. Brzozka, K., Finke, S. & Conzelmann, K. K. ( 2005; ). Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79, 7673–7681.[CrossRef]
    [Google Scholar]
  63. Brzozka, K., Finke, S. & Conzelmann, K. K. ( 2006; ). Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J Virol 80, 2675–2683.[CrossRef]
    [Google Scholar]
  64. Butler, D. ( 2004; ). Fatal fruit bat virus sparks epidemics in southern Asia. Nature 429, 7
    [Google Scholar]
  65. Caillaud, A., Hovanessian, A. G., Levy, D. E. & Marie, I. J. ( 2005; ). Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7. J Biol Chem 280, 17671–17677.[CrossRef]
    [Google Scholar]
  66. Camus-Bouclainville, C., Fiette, L., Bouchiha, S., Pignolet, B., Counor, D., Filipe, C., Gelfi, J. & Messud-Petit, F. ( 2004; ). A virulence factor of myxoma virus colocalizes with NF-κB in the nucleus and interferes with inflammation. J Virol 78, 2510–2516.[CrossRef]
    [Google Scholar]
  67. Cantrell, S. R. & Bresnahan, W. A. ( 2006; ). Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J Virol 80, 6188–6191.[CrossRef]
    [Google Scholar]
  68. Cao, W. & Liu, Y. J. ( 2007; ). Innate immune functions of plasmacytoid dendritic cells. Curr Opin Immunol 19, 24–30.[CrossRef]
    [Google Scholar]
  69. Capobianchi, M. R., Ankel, H., Ameglio, F., Paganelli, R., Pizzoli, P. M. & Dianzani, F. ( 1992; ). Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. AIDS Res Hum Retroviruses 8, 575–579.[CrossRef]
    [Google Scholar]
  70. Cardenas, W. B., Loo, Y. M., Gale, M., Jr, Hartman, A. L., Kimberlin, C. R., Martinez-Sobrido, L., Saphire, E. O. & Basler, C. F. ( 2006; ). Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol 80, 5168–5178.[CrossRef]
    [Google Scholar]
  71. Carlos, T. S., Fearns, R. & Randall, R. E. ( 2005; ). Interferon-induced alterations in the pattern of parainfluenza virus 5 transcription and protein synthesis and the induction of virus inclusion bodies. J Virol 79, 14112–14121.[CrossRef]
    [Google Scholar]
  72. Cassady, K. A. ( 2005; ). Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. J Virol 79, 8707–8715.[CrossRef]
    [Google Scholar]
  73. Castelli, J. C., Hassel, B. A., Maran, A., Paranjape, J., Hewitt, J. A., Li, X. L., Hsu, Y. T., Silverman, R. H. & Youle, R. J. ( 1998; ). The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ 5, 313–320.[CrossRef]
    [Google Scholar]
  74. Cattaneo, R. ( 1994; ). Biased (A→I) hypermutation of animal RNA virus genomes. Curr Opin Genet Dev 4, 895–900.[CrossRef]
    [Google Scholar]
  75. Chang, H. W., Watson, J. C. & Jacobs, B. L. ( 1992; ). The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A 89, 4825–4829.[CrossRef]
    [Google Scholar]
  76. Chariot, A., Leonardi, A., Muller, J., Bonif, M., Brown, K. & Siebenlist, U. ( 2002; ). Association of the adaptor TANK with the IκB kinase (IKK) regulator NEMO connects IKK complexes with IKKϵ and TBK1 kinases. J Biol Chem 277, 37029–37036.[CrossRef]
    [Google Scholar]
  77. Chatterjee-Kishore, M., van Den Akker, F. & Stark, G. R. ( 2000a; ). Adenovirus E1A down-regulates LMP2 transcription by interfering with the binding of Stat1 to IRF1. J Biol Chem 275, 20406–20411.[CrossRef]
    [Google Scholar]
  78. Chatterjee-Kishore, M., Wright, K. L., Ting, J. P. & Stark, G. R. ( 2000b; ). How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J 19, 4111–4122.[CrossRef]
    [Google Scholar]
  79. Chatziandreou, N., Young, D., Andrejeva, J., Goodbourn, S. & Randall, R. E. ( 2002; ). Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293, 234–242.[CrossRef]
    [Google Scholar]
  80. Chee, A. V. & Roizman, B. ( 2004; ). Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol 78, 4185–4196.[CrossRef]
    [Google Scholar]
  81. Chen, Z. J. ( 2005; ). Ubiquitin signalling in the NF-κB pathway. Nat Cell Biol 7, 758–765.[CrossRef]
    [Google Scholar]
  82. Chen, Z., Li, Y. & Krug, R. M. ( 1999; ). Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J 18, 2273–2283.[CrossRef]
    [Google Scholar]
  83. Chen, K., Huang, J., Zhang, C., Huang, S., Nunnari, G., Wang, F. X., Tong, X., Gao, L., Nikisher, K. & Zhang, H. ( 2006; ). Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J Virol 80, 7645–7657.[CrossRef]
    [Google Scholar]
  84. Cheng, G., Zhong, J. & Chisari, F. V. ( 2006; ). Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 103, 8499–8504.[CrossRef]
    [Google Scholar]
  85. Cheng, G., Zhong, J., Chung, J. & Chisari, F. V. ( 2007; ). Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci U S A 104, 9035–9040.[CrossRef]
    [Google Scholar]
  86. Child, S. J., Hanson, L. K., Brown, C. E., Janzen, D. M. & Geballe, A. P. ( 2006; ). Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J Virol 80, 10173–10180.[CrossRef]
    [Google Scholar]
  87. Childs, K., Stock, N., Ross, C., Andrejeva, J., Hilton, L., Skinner, M., Randall, R. & Goodbourn, S. ( 2007; ). mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359, 190–200.[CrossRef]
    [Google Scholar]
  88. Chin, K. C. & Cresswell, P. ( 2001; ). Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A 98, 15125–15130.[CrossRef]
    [Google Scholar]
  89. Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A. & Fu, X. Y. ( 1997; ). Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17, 5328–5337.
    [Google Scholar]
  90. Chinsangaram, J., Piccone, M. E. & Grubman, M. J. ( 1999; ). Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol 73, 9891–9898.
    [Google Scholar]
  91. Choe, S. S., Dodd, D. A. & Kirkegaard, K. ( 2005; ). Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337, 18–29.[CrossRef]
    [Google Scholar]
  92. Christen, V., Duong, F., Bernsmeier, C., Sun, D., Nassal, M. & Heim, M. H. ( 2007; ). Inhibition of alpha interferon signaling by hepatitis B virus. J Virol 81, 159–165.[CrossRef]
    [Google Scholar]
  93. Ciccaglione, A. R., Stellacci, E., Marcantonio, C., Muto, V., Equestre, M., Marsili, G., Rapicetta, M. & Battistini, A. ( 2007; ). Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes. J Virol 81, 202–214.[CrossRef]
    [Google Scholar]
  94. Civas, A., Island, M. L., Genin, P., Morin, P. & Navarro, S. ( 2002; ). Regulation of virus-induced interferon-A genes. Biochimie 84, 643–654.[CrossRef]
    [Google Scholar]
  95. Clark, M. E., Lieberman, P. M., Berk, A. J. & Dasgupta, A. ( 1993; ). Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol 13, 1232–1237.
    [Google Scholar]
  96. Clemens, M. J. ( 2003; ). Interferons and apoptosis. J Interferon Cytokine Res 23, 277–292.[CrossRef]
    [Google Scholar]
  97. Clemens, M. J. ( 2005; ). Translational control in virus-infected cells: models for cellular stress responses. Semin Cell Dev Biol 16, 13–20.[CrossRef]
    [Google Scholar]
  98. Colamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A. & Buller, R. M. L. ( 1995; ). Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon α transmembrane signaling. J Biol Chem 270, 15974–15978.[CrossRef]
    [Google Scholar]
  99. Connor, J. H. & Lyles, D. S. ( 2002; ). Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1. J Virol 76, 10177–10187.[CrossRef]
    [Google Scholar]
  100. Connor, J. H. & Lyles, D. S. ( 2005; ). Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translation. J Biol Chem 280, 13512–13519.[CrossRef]
    [Google Scholar]
  101. Conzelmann, K. K. ( 2005; ). Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J Virol 79, 5241–5248.[CrossRef]
    [Google Scholar]
  102. Cooray, S., Bahar, M. W., Abrescia, N. G., McVey, C. E., Bartlett, N. W., Chen, R. A., Stuart, D. I., Grimes, J. M. & Smith, G. L. ( 2007; ). Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 88, 1656–1666.[CrossRef]
    [Google Scholar]
  103. Croze, E., Usacheva, A., Asarnow, D., Minshall, R. D., Perez, H. D. & Colamonici, O. ( 2000; ). Receptor for activated C-kinase (RACK-1), a WD motif-containing protein, specifically associates with the human type I IFN receptor. J Immunol 165, 5127–5132.[CrossRef]
    [Google Scholar]
  104. Cuddihy, A. R., Wong, A. H., Tam, N. W., Li, S. & Koromilas, A. E. ( 1999a; ). The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18, 2690–2702.[CrossRef]
    [Google Scholar]
  105. Cuddihy, A. R., Li, S., Tam, N. W., Wong, A. H., Taya, Y., Abraham, N., Bell, J. C. & Koromilas, A. E. ( 1999b; ). Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol 19, 2475–2484.
    [Google Scholar]
  106. Cusson-Hermance, N., Khurana, S., Lee, T. H., Fitzgerald, K. A. & Kelliher, M. A. ( 2005; ). Rip1 mediates the Trif-dependent Toll-like receptor 3- and 4-induced NF-κB activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 280, 36560–36566.[CrossRef]
    [Google Scholar]
  107. Dai, C. & Krantz, S. B. ( 1999; ). Interferon γ induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93, 3309–3316.
    [Google Scholar]
  108. Das, S. & Dasgupta, A. ( 1993; ). Identification of the cleavage site and determinants required for poliovirus 3CPro-catalyzed cleavage of human TATA-binding transcription factor TBP. J Virol 67, 3326–3331.
    [Google Scholar]
  109. de Bouteiller, O., Merck, E., Hasan, U. A., Hubac, S., Benguigui, B., Trinchieri, G., Bates, E. E. & Caux, C. ( 2005; ). Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 280, 38133–38145.[CrossRef]
    [Google Scholar]
  110. De Clercq, E. ( 2006; ). Interferon and its inducers – a never-ending story: “old” and “new” data in a new perspective. J Infect Dis 194, S19–S26.[CrossRef]
    [Google Scholar]
  111. de Los Santos, T., de Avila Botton, S., Weiblen, R. & Grubman, M. J. ( 2006; ). The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol 80, 1906–1914.[CrossRef]
    [Google Scholar]
  112. de Lucas, S., Bartolome, J. & Carreno, V. ( 2005; ). Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes. J Infect Dis 191, 93–99.[CrossRef]
    [Google Scholar]
  113. Deb, D. K., Sassano, A., Lekmine, F., Majchrzak, B., Verma, A., Kambhampati, S., Uddin, S., Rahman, A., Fish, E. N. & Platanias, L. C. ( 2003; ). Activation of protein kinase Cδ by IFN-gamma. J Immunol 171, 267–273.[CrossRef]
    [Google Scholar]
  114. Decker, T., Lew, D. J. & Darnell, J. E. J. ( 1991; ). Two distinct alpha-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene. Mol Cell Biol 11, 5147–5153.
    [Google Scholar]
  115. Decman, V., Freeman, M. L., Kinchington, P. R. & Hendricks, R. L. ( 2005; ). Immune control of HSV-1 latency. Viral Immunol 18, 466–473.[CrossRef]
    [Google Scholar]
  116. Delale, T., Paquin, A., Asselin-Paturel, C., Dalod, M., Brizard, G., Bates, E. E., Kastner, P., Chan, S., Akira, S. & other authors ( 2005; ). MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-α release and initiation of immune responses in vivo. J Immunol 175, 6723–6732.[CrossRef]
    [Google Scholar]
  117. Delhaye, S., van Pesch, V. & Michiels, T. ( 2004; ). The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J Virol 78, 4357–4362.[CrossRef]
    [Google Scholar]
  118. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C. & Chen, Z. J. ( 2000; ). Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361.[CrossRef]
    [Google Scholar]
  119. Desmyter, J., Melnick, J. L. & Rawls, W. E. ( 1968; ). Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol 2, 955–961.
    [Google Scholar]
  120. Devaney, M. A., Vakharia, V. N., Lloyd, R. E., Ehrenfeld, E. & Grubman, M. J. ( 1988; ). Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol 62, 4407–4409.
    [Google Scholar]
  121. Diao, F., Li, S., Tian, Y., Zhang, M., Xu, L. G., Zhang, Y., Wang, R. P., Chen, D., Zhai, Z. & other authors ( 2007; ). Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci U S A 104, 11706–11711.[CrossRef]
    [Google Scholar]
  122. Didcock, L., Young, D. F., Goodbourn, S. & Randall, R. E. ( 1999a; ). The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73, 9928–9933.
    [Google Scholar]
  123. Didcock, L., Young, D. F., Goodbourn, S. & Randall, R. E. ( 1999b; ). Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol 73, 3125–3133.
    [Google Scholar]
  124. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. & Reis e Sousa, C. ( 2004; ). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303, 1529–1531.[CrossRef]
    [Google Scholar]
  125. Diebold, S. S., Massacrier, C., Akira, S., Paturel, C., Morel, Y. & Reis e Sousa, C. ( 2006; ). Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol 36, 3256–3267.[CrossRef]
    [Google Scholar]
  126. Dillon, P. J. & Parks, G. D. ( 2007; ). Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses. J Virol 81, 11116–11127.[CrossRef]
    [Google Scholar]
  127. DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A. & Marshall, W. L. ( 2004; ). Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB by the tumor necrosis factor superfamily of receptors, and inhibits NF-κB and IRF3 signaling by Toll-like receptors. J Biol Chem 279, 36570–36578.[CrossRef]
    [Google Scholar]
  128. Djavani, M., Rodas, J., Lukashevich, I. S., Horejsh, D., Pandolfi, P. P., Borden, K. L. & Salvato, M. S. ( 2001; ). Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol 75, 6204–6208.[CrossRef]
    [Google Scholar]
  129. Doepker, R. C., Hsu, W. L., Saffran, H. A. & Smiley, J. R. ( 2004; ). Herpes simplex virus virion host shutoff protein is stimulated by translation initiation factors eIF4B and eIF4H. J Virol 78, 4684–4699.[CrossRef]
    [Google Scholar]
  130. Doucas, V., Ishov, A. M., Romo, A., Juguilon, H., Weitzman, M. D., Evans, R. M. & Maul, G. G. ( 1996; ). Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10, 196–207.[CrossRef]
    [Google Scholar]
  131. Dragan, A. I., Hargreaves, V. V., Makeyeva, E. N. & Privalov, P. L. ( 2007; ). Mechanisms of activation of interferon regulator factor 3: the role of C-terminal domain phosphorylation in IRF-3 dimerization and DNA binding. Nucleic Acids Res 35, 3525–3534.[CrossRef]
    [Google Scholar]
  132. Duong, F. H., Filipowicz, M., Tripodi, M., La Monica, N. & Heim, M. H. ( 2004; ). Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 126, 263–277.[CrossRef]
    [Google Scholar]
  133. Duong, F. H., Christen, V., Filipowicz, M. & Heim, M. H. ( 2006; ). S-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro. Hepatology 43, 796–806.[CrossRef]
    [Google Scholar]
  134. Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. & Chen, Z. J. ( 2006; ). Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22, 245–257.[CrossRef]
    [Google Scholar]
  135. Edelmann, K. H., Richardson-Burns, S., Alexopoulou, L., Tyler, K. L., Flavell, R. A. & Oldstone, M. B. ( 2004; ). Does Toll-like receptor 3 play a biological role in virus infections? Virology 322, 231–238.[CrossRef]
    [Google Scholar]
  136. Ehrhardt, C., Wolff, T., Pleschka, S., Planz, O., Beermann, W., Bode, J. G., Schmolke, M. & Ludwig, S. ( 2007; ). The influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol 81, 3058–3067.[CrossRef]
    [Google Scholar]
  137. Elankumaran, S., Rockemann, D. & Samal, S. K. ( 2006; ). Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol 80, 7522–7534.[CrossRef]
    [Google Scholar]
  138. Elliott, J., Lynch, O. T., Suessmuth, Y., Qian, P., Boyd, C. R., Burrows, J. F., Buick, R., Stevenson, N. J., Touzelet, O. & other authors ( 2007; ). Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 81, 3428–3436.[CrossRef]
    [Google Scholar]
  139. Ellis, M. J. & Goodbourn, S. ( 1994; ). NF-κB-independent activation of β-interferon expression in mouse F9 embryonal carcinoma cells. Nucleic Acids Res 22, 4489–4496.[CrossRef]
    [Google Scholar]
  140. Epperson, D. E., Arnold, D., Spies, T., Cresswell, P., Pober, J. S. & Johnson, D. R. ( 1992; ). Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol 149, 3297–3301.
    [Google Scholar]
  141. Erlandsson, L., Blumenthal, R., Eloranta, M. L., Engel, H., Alm, G., Weiss, S. & Leanderson, T. ( 1998; ). Interferon-β is required for interferon-α production in mouse fibroblasts. Curr Biol 8, 223–226.[CrossRef]
    [Google Scholar]
  142. Espert, L., Codogno, P. & Biard-Piechaczyk, M. ( 2007; ). Involvement of autophagy in viral infections: antiviral function and subversion by viruses. J Mol Med 85, 811–823.[CrossRef]
    [Google Scholar]
  143. Etchison, D., Milburn, S. C., Edery, I., Sonenberg, N. & Hershey, J. W. ( 1982; ). Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257, 14806–14810.
    [Google Scholar]
  144. Everett, R. D. ( 2001; ). DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266–7273.[CrossRef]
    [Google Scholar]
  145. Everett, R. D. ( 2006; ). Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol 8, 365–374.[CrossRef]
    [Google Scholar]
  146. Everett, R. D. & Chelbi-Alix, M. K. ( 2007; ). PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89, 819–830.[CrossRef]
    [Google Scholar]
  147. Everly, D. N., Jr, Feng, P., Mian, I. S. & Read, G. S. ( 2002; ). mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease. J Virol 76, 8560–8571.[CrossRef]
    [Google Scholar]
  148. Feng, Z., Cerveny, M., Yan, Z. & He, B. ( 2007; ). The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol 81, 182–192.[CrossRef]
    [Google Scholar]
  149. Fensterl, V., Grotheer, D., Berk, I., Schlemminger, S., Vallbracht, A. & Dotzauer, A. ( 2005; ). Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of β interferon. J Virol 79, 10968–10977.[CrossRef]
    [Google Scholar]
  150. Ferko, B., Stasakova, J., Romanova, J., Kittel, C., Sereinig, S., Katinger, H. & Egorov, A. ( 2004; ). Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol 78, 13037–13045.[CrossRef]
    [Google Scholar]
  151. Fernandez, M., Quiroga, J. A. & Carreno, V. ( 2003; ). Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J Gen Virol 84, 2073–2082.[CrossRef]
    [Google Scholar]
  152. Fernandez-Sesma, A., Marukian, S., Ebersole, B. J., Kaminski, D., Park, M. S., Yuen, T., Sealfon, S. C., Garcia-Sastre, A. & Moran, T. M. ( 2006; ). Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80, 6295–6304.[CrossRef]
    [Google Scholar]
  153. Ferran, M. C. & Lucas-Lenard, J. M. ( 1997; ). The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol 71, 371–377.
    [Google Scholar]
  154. Ferrantini, M., Capone, I. & Belardelli, F. ( 2007; ). Interferon-α and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 89, 884–893.[CrossRef]
    [Google Scholar]
  155. Fitzgerald, K. A., Palsson-McDermott, E. M., Bowie, A. G., Jefferies, C. A., Mansell, A. S., Brady, G., Brint, E., Dunne, A., Gray, P. & other authors ( 2001; ). Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78–83.[CrossRef]
    [Google Scholar]
  156. Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S. M. & Maniatis, T. ( 2003; ). IKKϵ and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4, 491–496.
    [Google Scholar]
  157. Fortes, P., Beloso, A. & Ortin, J. ( 1994; ). Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J 13, 704–712.
    [Google Scholar]
  158. Frahm, T., Hauser, H. & Koster, M. ( 2006; ). IFN-type-I-mediated signaling is regulated by modulation of STAT2 nuclear export. J Cell Sci 119, 1092–1104.[CrossRef]
    [Google Scholar]
  159. Frese, M., Pietschmann, T., Moradpour, D., Haller, O. & Bartenschlager, R. ( 2001; ). Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J Gen Virol 82, 723–733.
    [Google Scholar]
  160. Friedman, J. M. & Horwitz, M. S. ( 2002; ). Inhibition of tumor necrosis factor alpha-induced NF-κB activation by the adenovirus E3–10.4/14.5K complex. J Virol 76, 5515–5521.[CrossRef]
    [Google Scholar]
  161. Friedrichs, W. E., Reddy, S. V., Bruder, J. M., Cundy, T., Cornish, J., Singer, F. R. & Roodman, G. D. ( 2002; ). Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res 17, 145–151.[CrossRef]
    [Google Scholar]
  162. Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S. A., Palese, P. & Baric, R. S. ( 2007; ). Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J Virol 81, 9812–9824.[CrossRef]
    [Google Scholar]
  163. Frolova, E. I., Fayzulin, R. Z., Cook, S. H., Griffin, D. E., Rice, C. M. & Frolov, I. ( 2002; ). Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection. J Virol 76, 11254–11264.[CrossRef]
    [Google Scholar]
  164. Fujita, T., Onoguchi, K., Onomoto, K., Hirai, R. & Yoneyama, M. ( 2007; ). Triggering antiviral response by RIG-I-related RNA helicases. Biochimie 89, 754–760.[CrossRef]
    [Google Scholar]
  165. Gack, M. U., Shin, Y. C., Joo, C. H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z. & other authors ( 2007; ). TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916–920.[CrossRef]
    [Google Scholar]
  166. Gaddy, D. F. & Lyles, D. S. ( 2007; ). Oncolytic vesicular stomatitis virus induces apoptosis via signaling through PKR, Fas, and Daxx. J Virol 81, 2792–2804.[CrossRef]
    [Google Scholar]
  167. Garcia, M. A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C. & Esteban, M. ( 2006; ). Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70, 1032–1060.[CrossRef]
    [Google Scholar]
  168. Garcia-Sastre, A. ( 2007; ). De-ISGylating and de-ubiquitinating activities of viral OUT-like proteins. In Gordon Research Conference 2007: Viruses and Cells, 3–8 June 2007 (oral presentation). Tilton School, Tilton, NH, USA.
  169. Garcin, D., Latorre, P. & Kolakofsky, D. ( 1999; ). Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol 73, 6559–6565.
    [Google Scholar]
  170. Garcin, D., Curran, J. & Kolakofsky, D. ( 2000; ). Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J Virol 74, 8823–8830.[CrossRef]
    [Google Scholar]
  171. Garcin, D., Curran, J., Itoh, M. & Kolakofsky, D. ( 2001; ). Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J Virol 75, 6800–6807.[CrossRef]
    [Google Scholar]
  172. Garcin, D., Marq, J. B., Strahle, L., le Mercier, P. & Kolakofsky, D. ( 2002; ). All four Sendai virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295, 256–265.[CrossRef]
    [Google Scholar]
  173. Garcin, D., Marq, J. B., Goodbourn, S. & Kolakofsky, D. ( 2003; ). The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J Virol 77, 2321–2329.[CrossRef]
    [Google Scholar]
  174. Garmashova, N., Gorchakov, R., Frolova, E. & Frolov, I. ( 2006; ). Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription. J Virol 80, 5686–5696.[CrossRef]
    [Google Scholar]
  175. Georgel, P., Jiang, Z., Kunz, S., Janssen, E., Mols, J., Hoebe, K., Bahram, S., Oldstone, M. B. & Beutler, B. ( 2007; ). Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 362, 304–313.[CrossRef]
    [Google Scholar]
  176. Giannakopoulos, N. V., Luo, J. K., Papov, V., Zou, W., Lenschow, D. J., Jacobs, B. S., Borden, E. C., Li, J., Virgin, H. W. & Zhang, D. E. ( 2005; ). Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 336, 496–506.[CrossRef]
    [Google Scholar]
  177. Gil, J., Alcami, J. & Esteban, M. ( 1999; ). Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the α subunit of eukaryotic translation initiation factor 2 and NF-κB. Mol Cell Biol 19, 4653–4663.
    [Google Scholar]
  178. Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M. S. & Colonna, M. ( 2006; ). Essential role of mda-5 in type I IFN responses to polyriboinosinic : polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 103, 8459–8464.[CrossRef]
    [Google Scholar]
  179. Goodbourn, S., Zinn, K. & Maniatis, T. ( 1985; ). Human β-interferon gene expression is regulated by an inducible enhancer element. Cell 41, 509–520.[CrossRef]
    [Google Scholar]
  180. Gorchakov, R., Frolova, E. & Frolov, I. ( 2005; ). Inhibition of transcription and translation in Sindbis virus-infected cells. J Virol 79, 9397–9409.[CrossRef]
    [Google Scholar]
  181. Gordon, M. T., Anderson, D. C. & Sharpe, P. T. ( 1991; ). Canine distemper virus localised in bone cells of patients with Paget's disease. Bone 12, 195–201.[CrossRef]
    [Google Scholar]
  182. Gotoh, B., Takeuchi, K., Komatsu, T. & Yokoo, J. ( 2003a; ). The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 77, 3360–3370.[CrossRef]
    [Google Scholar]
  183. Gotoh, B., Komatsu, T., Takeuchi, K. & Yokoo, J. ( 2003b; ). The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site. Virology 316, 29–40.[CrossRef]
    [Google Scholar]
  184. Gradi, A., Svitkin, Y. V., Imataka, H. & Sonenberg, N. ( 1998; ). Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci U S A 95, 11089–11094.[CrossRef]
    [Google Scholar]
  185. Graff, J. W., Ewen, J., Ettayebi, K. & Hardy, M. E. ( 2007; ). Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability. J Gen Virol 88, 613–620.[CrossRef]
    [Google Scholar]
  186. Graham, R. R., Kyogoku, C., Sigurdsson, S., Vlasova, I. A., Davies, L. R., Baechler, E. C., Plenge, R. M., Koeuth, T., Ortmann, W. A. & other authors ( 2007; ). Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104, 6758–6763.[CrossRef]
    [Google Scholar]
  187. Guo, B. & Cheng, G. ( 2007; ). Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 282, 11817–11826.[CrossRef]
    [Google Scholar]
  188. Guo, J., Hui, D. J., Merrick, W. C. & Sen, G. C. ( 2000; ). A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J 19, 6891–6899.[CrossRef]
    [Google Scholar]
  189. Guo, Z., Chen, L. M., Zeng, H., Gomez, J. A., Plowden, J., Fujita, T., Katz, J. M., Donis, R. O. & Sambhara, S. ( 2006; ). NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36, 263–269.
    [Google Scholar]
  190. Gustin, K. E. & Sarnow, P. ( 2001; ). Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J 20, 240–249.[CrossRef]
    [Google Scholar]
  191. Hacker, H., Redecke, V., Blagoev, B., Kratchmarova, I., Hsu, L. C., Wang, G. G., Kamps, M. P., Raz, E., Wagner, H. & other authors ( 2006; ). Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204–207.[CrossRef]
    [Google Scholar]
  192. Hagglund, R. & Roizman, B. ( 2004; ). Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol 78, 2169–2178.[CrossRef]
    [Google Scholar]
  193. Hagmaier, K., Gelderblom, H. R. & Kochs, G. ( 2004; ). Functional comparison of the two gene products of Thogoto virus segment 6. J Gen Virol 85, 3699–3708.[CrossRef]
    [Google Scholar]
  194. Hagmaier, K., Stock, N., Precious, B., Childs, K., Wang, L. F., Goodbourn, S. & Randall, R. E. ( 2007; ). Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs. J Gen Virol 88, 956–966.[CrossRef]
    [Google Scholar]
  195. Hakki, M. & Geballe, A. P. ( 2005; ). Double-stranded RNA binding by human cytomegalovirus pTRS1. J Virol 79, 7311–7318.[CrossRef]
    [Google Scholar]
  196. Hale, B. G., Jackson, D., Chen, Y. H., Lamb, R. A. & Randall, R. E. ( 2006; ). Influenza A virus NS1 protein binds p85β and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A 103, 14194–14199.[CrossRef]
    [Google Scholar]
  197. Haller, O., Staeheli, P. & Kochs, G. ( 2007; ). Interferon-induced Mx proteins in antiviral host defense. Biochimie 89, 812–818.[CrossRef]
    [Google Scholar]
  198. Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A. & O'Neill, L. A. ( 2003; ). The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med 197, 343–351.[CrossRef]
    [Google Scholar]
  199. Hartman, A. L., Dover, J. E., Towner, J. S. & Nichol, S. T. ( 2006; ). Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J Virol 80, 6430–6440.[CrossRef]
    [Google Scholar]
  200. Hartmann, R., Justesen, J., Sarkar, S. N., Sen, G. C. & Yee, V. C. ( 2003; ). Crystal structure of the 2′-specific and double-stranded RNA-activated interferon-induced antiviral protein 2′-5′-oligoadenylate synthetase. Mol Cell 12, 1173–1185.[CrossRef]
    [Google Scholar]
  201. Hartwig, D., Schutte, C., Warnecke, J., Dorn, I., Hennig, H., Kirchner, H. & Schlenke, P. ( 2006; ). The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-α-stimulated host cells. J Viral Hepat 13, 150–157.[CrossRef]
    [Google Scholar]
  202. Hata, N., Sato, M., Takaoka, A., Asagiri, M., Tanaka, N. & Taniguchi, T. ( 2001; ). Constitutive IFN-α/β signal for efficient IFN-α/β gene induction by virus. Biochem Biophys Res Commun 285, 518–525.[CrossRef]
    [Google Scholar]
  203. Hatziioannou, T., Perez-Caballero, D., Yang, A., Cowan, S. & Bieniasz, P. D. ( 2004; ). Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α. Proc Natl Acad Sci U S A 101, 10774–10779.[CrossRef]
    [Google Scholar]
  204. Hayden, M. S. & Ghosh, S. ( 2004; ). Signaling to NF-κB. Genes Dev 18, 2195–2224.[CrossRef]
    [Google Scholar]
  205. Hayman, A., Comely, S., Lackenby, A., Murphy, S., McCauley, J., Goodbourn, S. & Barclay, W. ( 2006; ). Variation in the ability of human influenza A viruses to induce and inhibit the IFN-β pathway. Virology 347, 52–64.[CrossRef]
    [Google Scholar]
  206. Hayman, A., Comely, S., Lackenby, A., Hartgroves, L. C., Goodbourn, S., McCauley, J. W. & Barclay, W. S. ( 2007; ). NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J Virol 81, 2318–2327.[CrossRef]
    [Google Scholar]
  207. Haynes, L. M., Moore, D. D., Kurt-Jones, E. A., Finberg, R. W., Anderson, L. J. & Tripp, R. A. ( 2001; ). Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75, 10730–10737.[CrossRef]
    [Google Scholar]
  208. He, B., Lin, G. Y., Durbin, J. E., Durbin, R. K. & Lamb, R. A. ( 2001; ). The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol 75, 4068–4079.[CrossRef]
    [Google Scholar]
  209. He, B., Paterson, R. G., Stock, N., Durbin, J. E., Durbin, R. K., Goodbourn, S., Randall, R. E. & Lamb, R. A. ( 2002; ). Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-β induction and interferon signaling. Virology 303, 15–32.[CrossRef]
    [Google Scholar]
  210. Heil, F., Ahmad-Nejad, P., Hemmi, H., Hochrein, H., Ampenberger, F., Gellert, T., Dietrich, H., Lipford, G., Takeda, K. & other authors ( 2003; ). The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 33, 2987–2997.[CrossRef]
    [Google Scholar]
  211. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H. & Bauer, S. ( 2004; ). Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303, 1526–1529.[CrossRef]
    [Google Scholar]
  212. Heim, M. H., Moradpour, D. & Blum, H. E. ( 1999; ). Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 73, 8469–8475.
    [Google Scholar]
  213. Helbig, K. J., Lau, D. T., Semendric, L., Harley, H. A. & Beard, M. R. ( 2005; ). Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42, 702–710.[CrossRef]
    [Google Scholar]
  214. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K. & Akira, S. ( 2002; ). Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3, 196–200.[CrossRef]
    [Google Scholar]
  215. Her, L. S., Lund, E. & Dahlberg, J. E. ( 1997; ). Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276, 1845–1848.[CrossRef]
    [Google Scholar]
  216. Herzer, K., Weyer, S., Krammer, P. H., Galle, P. R. & Hofmann, T. G. ( 2005; ). Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res 65, 10830–10837.[CrossRef]
    [Google Scholar]
  217. Hilton, L., Moganeradj, K., Zhang, G., Chen, Y. H., Randall, R. E., McCauley, J. W. & Goodbourn, S. ( 2006; ). The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor-3 and targets it for proteasomal degradation. J Virol 80, 11723–11732.[CrossRef]
    [Google Scholar]
  218. Hiscott, J., Lin, R., Nakhaei, P. & Paz, S. ( 2006a; ). MasterCARD: a priceless link to innate immunity. Trends Mol Med 12, 53–56.[CrossRef]
    [Google Scholar]
  219. Hiscott, J., Nguyen, T. L., Arguello, M., Nakhaei, P. & Paz, S. ( 2006b; ). Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses. Oncogene 25, 6844–6867.[CrossRef]
    [Google Scholar]
  220. Ho, L. J., Hung, L. F., Weng, C. Y., Wu, W. L., Chou, P., Lin, Y. L., Chang, D. M., Tai, T. Y. & Lai, J. H. ( 2005; ). Dengue virus type 2 antagonizes IFN-α but not IFN-γ antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol 174, 8163–8172.[CrossRef]
    [Google Scholar]
  221. Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J., Lin, P., Mann, N. & other authors ( 2003; ). Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743–748.[CrossRef]
    [Google Scholar]
  222. Honda, K. & Taniguchi, T. ( 2006; ). IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6, 644–658.[CrossRef]
    [Google Scholar]
  223. Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y., Takaoka, A., Yeh, W. C. & Taniguchi, T. ( 2004; ). Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 101, 15416–15421.[CrossRef]
    [Google Scholar]
  224. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C. & Taniguchi, T. ( 2005a; ). Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035–1040.[CrossRef]
    [Google Scholar]
  225. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A. & other authors ( 2005b; ). IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434, 772–777.[CrossRef]
    [Google Scholar]
  226. Hoppe, A., Beech, S. J., Dimmock, J. & Leppard, K. N. ( 2006; ). Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J Virol 80, 3042–3049.[CrossRef]
    [Google Scholar]
  227. Horng, T., Barton, G. M. & Medzhitov, R. ( 2001; ). TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2, 835–841.[CrossRef]
    [Google Scholar]
  228. Hornung, V., Ellegast, J., Kim, S., Brzozka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K. K. & other authors ( 2006; ). 5′-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997.[CrossRef]
    [Google Scholar]
  229. Horvath, C. M. ( 2004; ). Silencing STATs: lessons from paramyxovirus interferon evasion. Cytokine Growth Factor Rev 15, 117–127.[CrossRef]
    [Google Scholar]
  230. Hoshino, K., Sugiyama, T., Matsumoto, M., Tanaka, T., Saito, M., Hemmi, H., Ohara, O., Akira, S. & Kaisho, T. ( 2006; ). IκB kinase-α is critical for interferon-α production induced by Toll-like receptors 7 and 9. Nature 440, 949–953.[CrossRef]
    [Google Scholar]
  231. Hoyland, J. A., Dixon, J. A., Berry, J. L., Davies, M., Selby, P. L. & Mee, A. P. ( 2003; ). A comparison of in situ hybridisation, reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ-RT-PCR for the detection of canine distemper virus RNA in Paget's disease. J Virol Methods 109, 253–259.[CrossRef]
    [Google Scholar]
  232. Huang, Z., Krishnamurthy, S., Panda, A. & Samal, S. K. ( 2003; ). Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist. J Virol 77, 8676–8685.[CrossRef]
    [Google Scholar]
  233. Huang, J., Smirnov, S. V., Lewis-Antes, A., Balan, M., Li, W., Tang, S., Silke, G. V., Putz, M. M., Smith, G. L. & Kotenko, S. V. ( 2007; ). Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A 104, 9822–9827.[CrossRef]
    [Google Scholar]
  234. Hui, D. J., Bhasker, C. R., Merrick, W. C. & Sen, G. C. ( 2003; ). Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J Biol Chem 278, 39477–39482.[CrossRef]
    [Google Scholar]
  235. Hui, D. J., Terenzi, F., Merrick, W. C. & Sen, G. C. ( 2005; ). Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. J Biol Chem 280, 3433–3440.[CrossRef]
    [Google Scholar]
  236. Hunter, W. D., Martuza, R. L., Feigenbaum, F., Todo, T., Mineta, T., Yazaki, T., Toda, M., Newsome, J. T., Platenberg, R. C. & other authors ( 1999; ). Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. J Virol 73, 6319–6326.
    [Google Scholar]
  237. Huye, L. E., Ning, S., Kelliher, M. & Pagano, J. S. ( 2007; ). Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol Cell Biol 27, 2910–2918.[CrossRef]
    [Google Scholar]
  238. Imani, F. & Jacobs, B. L. ( 1988; ). Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc Natl Acad Sci U S A 85, 7887–7891.[CrossRef]
    [Google Scholar]
  239. Iordanov, M. S., Kirsch, J. D., Ryabinina, O. P., Wong, J., Spitz, P. N., Korcheva, V. B., Thorburn, A. & Magun, B. E. ( 2005; ). Recruitment of TRADD, FADD, and caspase 8 to double-stranded RNA-triggered death inducing signaling complexes (dsRNA-DISCs). Apoptosis 10, 167–176.[CrossRef]
    [Google Scholar]
  240. Iqbal, M., Poole, E., Goodbourn, S. & McCauley, J. W. ( 2004; ). Role for bovine viral diarrhea virus Erns glycoprotein in the control of activation of beta interferon by double-stranded RNA. J Virol 78, 136–145.[CrossRef]
    [Google Scholar]
  241. Isaacs, A. & Lindenmann, J. ( 1957; ). Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147, 258–267.[CrossRef]
    [Google Scholar]
  242. Ishii, K. J., Coban, C., Kato, H., Takahashi, K., Torii, Y., Takeshita, F., Ludwig, H., Sutter, G., Suzuki, K. & other authors ( 2006; ). A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7, 40–48.[CrossRef]
    [Google Scholar]
  243. Ito, T., Yang, M. & May, W. S. ( 1999; ). RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J Biol Chem 274, 15427–15432.[CrossRef]
    [Google Scholar]
  244. Iwasaki, A. ( 2007; ). Role of autophagy in innate viral recognition. Autophagy 3, 354–356.[CrossRef]
    [Google Scholar]
  245. Jackson, W. T., Giddings, T. H., Jr, Taylor, M. P., Mulinyawe, S., Rabinovitch, M., Kopito, R. R. & Kirkegaard, K. ( 2005; ). Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 3, e156 [CrossRef]
    [Google Scholar]
  246. Jacobs, B. L. & Langland, J. O. ( 1998; ). Reovirus sigma 3 protein: dsRNA binding and inhibition of RNA-activated protein kinase. Curr Top Microbiol Immunol 233, 185–196.
    [Google Scholar]
  247. Jaworska, J., Gravel, A., Fink, K., Grandvaux, N. & Flamand, L. ( 2007; ). Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein. J Virol 81, 5737–5748.[CrossRef]
    [Google Scholar]
  248. Jennings, S., Martinez-Sobrido, L., Garcia-Sastre, A., Weber, F. & Kochs, G. ( 2005; ). Thogoto virus ML protein suppresses IRF3 function. Virology 331, 63–72.[CrossRef]
    [Google Scholar]
  249. Jiang, Z., Mak, T. W., Sen, G. & Li, X. ( 2004; ). Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β. Proc Natl Acad Sci U S A 101, 3533–3538.[CrossRef]
    [Google Scholar]
  250. Joachims, M., Van Breugel, P. C. & Lloyd, R. E. ( 1999; ). Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 73, 718–727.
    [Google Scholar]
  251. Johnsen, I. B., Nguyen, T. T., Ringdal, M., Tryggestad, A. M., Bakke, O., Lien, E., Espevik, T. & Anthonsen, M. W. ( 2006; ). Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J 25, 3335–3346.[CrossRef]
    [Google Scholar]
  252. Johnson, C. L. & Gale, M., Jr ( 2006; ). CARD games between virus and host get a new player. Trends Immunol 27, 1–4.[CrossRef]
    [Google Scholar]
  253. Johnston, M. D. ( 1981; ). The characteristics required for a Sendai virus preparation to induce high levels of interferon in human lymphoblastoid cells. J Gen Virol 56, 175–184.[CrossRef]
    [Google Scholar]
  254. Johnston, J. B., Nazarian, S. H., Natale, R. & McFadden, G. ( 2005; ). Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses. Virology 332, 235–248.[CrossRef]
    [Google Scholar]
  255. Jones, M., Davidson, A., Hibbert, L., Gruenwald, P., Schlaak, J., Ball, S., Foster, G. R. & Jacobs, M. ( 2005; ). Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 79, 5414–5420.[CrossRef]
    [Google Scholar]
  256. Joo, M., Hahn, Y. S., Kwon, M., Sadikot, R. T., Blackwell, T. S. & Christman, J. W. ( 2005; ). Hepatitis C virus core protein suppresses NF-κB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol 79, 7648–7657.[CrossRef]
    [Google Scholar]
  257. Joo, C. H., Shin, Y. C., Gack, M., Wu, L., Levy, D. & Jung, J. U. ( 2007; ). Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3. J Virol 81, 8282–8292.[CrossRef]
    [Google Scholar]
  258. Jost, S., Turelli, P., Mangeat, B., Protzer, U. & Trono, D. ( 2007; ). Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons. J Virol 81, 10588–10596.[CrossRef]
    [Google Scholar]
  259. Jounai, N., Takeshita, F., Kobiyama, K., Sawano, A., Miyawaki, A., Xin, K. Q., Ishii, K. J., Kawai, T., Akira, S. & other authors ( 2007; ). The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc Natl Acad Sci U S A 104, 14050–14055.[CrossRef]
    [Google Scholar]
  260. Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G. & Bauer, S. ( 2002; ). Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3, 499 [CrossRef]
    [Google Scholar]
  261. Kanayama, A., Seth, R. B., Sun, L., Ea, C. K., Hong, M., Shaito, A., Chiu, Y. H., Deng, L. & Chen, Z. J. ( 2004; ). TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol Cell 15, 535–548.[CrossRef]
    [Google Scholar]
  262. Kang, H., Kim, E. T., Lee, H. R., Park, J. J., Go, Y. Y., Choi, C. Y. & Ahn, J. H. ( 2006; ). Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein. J Gen Virol 87, 2181–2190.[CrossRef]
    [Google Scholar]
  263. Kariko, K., Buckstein, M., Ni, H. & Weissman, D. ( 2005; ). Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165–175.[CrossRef]
    [Google Scholar]
  264. Karin, M. ( 2006; ). Nuclear factor-κB in cancer development and progression. Nature 441, 431–436.[CrossRef]
    [Google Scholar]
  265. Kato, A., Ohnishi, Y., Kohase, M., Saito, S., Tashiro, M. & Nagai, Y. ( 2001; ). Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol 75, 3802–3810.[CrossRef]
    [Google Scholar]
  266. Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T. & other authors ( 2005; ). Cell type-specific involvement of RIG-I in antiviral response. Immunity 23, 19–28.[CrossRef]
    [Google Scholar]
  267. Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T. & other authors ( 2006; ). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101–105.[CrossRef]
    [Google Scholar]
  268. Katsoulidis, E., Li, Y., Mears, H. & Platanias, L. C. ( 2005; ). The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J Interferon Cytokine Res 25, 749–756.[CrossRef]
    [Google Scholar]
  269. Kaukinen, P., Sillanpaa, M., Kotenko, S., Lin, R., Hiscott, J., Melen, K. & Julkunen, I. ( 2006; ). Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol J 3, 66 [CrossRef]
    [Google Scholar]
  270. Kaur, S., Uddin, S. & Platanias, L. C. ( 2005; ). The PI3′ kinase pathway in interferon signaling. J Interferon Cytokine Res 25, 780–787.[CrossRef]
    [Google Scholar]
  271. Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J. & other authors ( 2004; ). Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5, 1061–1068.[CrossRef]
    [Google Scholar]
  272. Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O. & Akira, S. ( 2005; ). IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6, 981–988.[CrossRef]
    [Google Scholar]
  273. Kawakami, T., Matsumoto, M., Sato, M., Harada, H., Taniguchi, T. & Kitagawa, M. ( 1995; ). Possible involvement of the transcription factor ISGF3γ in virus-induced expression of the IFN-β gene. FEBS Lett 358, 225–229.[CrossRef]
    [Google Scholar]
  274. Keckesova, Z., Ylinen, L. M. & Towers, G. J. ( 2004; ). The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A 101, 10780–10785.[CrossRef]
    [Google Scholar]
  275. Kerscher, O., Felberbaum, R. & Hochstrasser, M. ( 2006; ). Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22, 159–180.[CrossRef]
    [Google Scholar]
  276. Khanna, K. M., Lepisto, A. J., Decman, V. & Hendricks, R. L. ( 2004; ). Immune control of herpes simplex virus during latency. Curr Opin Immunol 16, 463–469.[CrossRef]
    [Google Scholar]
  277. Kim, M. J., Latham, A. G. & Krug, R. M. ( 2002; ). Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A 99, 10096–10101.[CrossRef]
    [Google Scholar]
  278. Kim, C. S., Jung, J. H., Wakita, T., Yoon, S. K. & Jang, S. K. ( 2007; ). Monitoring the antiviral effect of alpha interferon on individual cells. J Virol 81, 8814–8820.[CrossRef]
    [Google Scholar]
  279. King, P. & Goodbourn, S. ( 1994; ). The β-interferon promoter responds to priming through multiple independent regulatory elements. J Biol Chem 269, 30609–30615.
    [Google Scholar]
  280. Kirchweger, R., Ziegler, E., Lamphear, B. J., Waters, D., Liebig, H. D., Sommergruber, W., Sobrino, F., Hohenadl, C., Blaas, D. & other authors ( 1994; ). Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4γ. J Virol 68, 5677–5684.
    [Google Scholar]
  281. Kochs, G., Trost, M., Janzen, C. & Haller, O. ( 1998; ). MxA GTPase: oligomerization and GTP-dependent interaction with viral RNP target structures. Methods 15, 255–263.[CrossRef]
    [Google Scholar]
  282. Kochs, G., Garcia-Sastre, A. & Martinez-Sobrido, L. ( 2007; ). Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81, 7011–7021.[CrossRef]
    [Google Scholar]
  283. Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. & Murali-Krishna, K. ( 2005; ). Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202, 637–650.[CrossRef]
    [Google Scholar]
  284. Komatsu, T., Takeuchi, K., Yokoo, J. & Gotoh, B. ( 2002; ). Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett 511, 139–144.[CrossRef]
    [Google Scholar]
  285. Komatsu, T., Takeuchi, K. & Gotoh, B. ( 2007; ). Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production. Microbes Infect 9, 954–962.[CrossRef]
    [Google Scholar]
  286. Kopecky-Bromberg, S. A., Martinez-Sobrido, L., Frieman, M., Baric, R. A. & Palese, P. ( 2007; ). Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81, 548–557.[CrossRef]
    [Google Scholar]
  287. Kozuka, Y., Yamashita, Y., Kawano, M., Tsurudome, M., Ito, M., Nishio, M., Komada, H. & Ito, Y. ( 2003; ). Identification of amino acids essential for the human parainfluenza type 2 virus V protein to lower the intracellular levels of the STAT2. Virology 317, 208–219.[CrossRef]
    [Google Scholar]
  288. Kozyrev, S. V., Lewen, S., Reddy, P. M., Pons-Estel, B., Witte, T., Junker, P., Laustrup, H., Gutierrez, C., Suarez, A. & other authors ( 2007; ). Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56, 1234–1241.[CrossRef]
    [Google Scholar]
  289. Krishnamurthy, S., Takimoto, T., Scroggs, R. A. & Portner, A. ( 2006; ). Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines. J Virol 80, 5145–5155.[CrossRef]
    [Google Scholar]
  290. Krug, A., French, A. R., Barchet, W., Fischer, J. A., Dzionek, A., Pingel, J. T., Orihuela, M. M., Akira, S., Yokoyama, W. M. & Colonna, M. ( 2004; ). TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21, 107–119.[CrossRef]
    [Google Scholar]
  291. Kubota, T., Yokosawa, N., Yokota, S. & Fujii, N. ( 2001; ). C terminal Cys-rich region of mumps virus structural V protein correlates with block of interferon α and γ signal transduction pathway through decrease of STAT 1-α. Biochem Biophys Res Commun 283, 255–259.[CrossRef]
    [Google Scholar]
  292. Kubota, T., Yokosawa, N., Yokota, S. & Fujii, N. ( 2002; ). Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J Virol 76, 12676–12682.[CrossRef]
    [Google Scholar]
  293. Kubota, T., Yokosawa, N., Yokota, S., Fujii, N., Tashiro, M. & Kato, A. ( 2005; ). Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. J Virol 79, 4451–4459.[CrossRef]
    [Google Scholar]
  294. Kumar, K. P., McBride, K. M., Weaver, B. K., Dingwall, C. & Reich, N. C. ( 2000; ). Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol Cell Biol 20, 4159–4168.[CrossRef]
    [Google Scholar]
  295. Kumar, H., Kawai, T., Kato, H., Sato, S., Takahashi, K., Coban, C., Yamamoto, M., Uematsu, S., Ishii, K. J. & other authors ( 2006; ). Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203, 1795–1803.[CrossRef]
    [Google Scholar]
  296. Kumar, P. P., Bischof, O., Purbey, P. K., Notani, D., Urlaub, H., Dejean, A. & Galande, S. ( 2007; ). Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 9, 45–56.[CrossRef]
    [Google Scholar]
  297. Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., Walsh, E. E., Freeman, M. W., Golenbock, D. T. & other authors ( 2000; ). Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1, 398–401.[CrossRef]
    [Google Scholar]
  298. Kyogoku, C. & Tsuchiya, N. ( 2007; ). A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 8, 445–455.[CrossRef]
    [Google Scholar]
  299. La Rocca, S. A., Herbert, R. J., Crooke, H., Drew, T. W., Wileman, T. E. & Powell, P. P. ( 2005; ). Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro. J Virol 79, 7239–7247.[CrossRef]
    [Google Scholar]
  300. Langland, J. O., Pettiford, S., Jiang, B. & Jacobs, B. L. ( 1994; ). Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. J Virol 68, 3821–3829.
    [Google Scholar]
  301. Langland, J. O., Cameron, J. M., Heck, M. C., Jancovich, J. K. & Jacobs, B. L. ( 2006; ). Inhibition of PKR by RNA and DNA viruses. Virus Res 119, 100–110.[CrossRef]
    [Google Scholar]
  302. Le Bon, A. & Tough, D. F. ( 2002; ). Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14, 432–436.[CrossRef]
    [Google Scholar]
  303. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P. & Tough, D. F. ( 2003; ). Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4, 1009–1015.[CrossRef]
    [Google Scholar]
  304. Le Bon, A., Durand, V., Kamphuis, E., Thompson, C., Bulfone-Paus, S., Rossmann, C., Kalinke, U. & Tough, D. F. ( 2006; ). Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 176, 4682–4689.[CrossRef]
    [Google Scholar]
  305. Le May, N., Dubaele, S., Proietti De Santis, L., Billecocq, A., Bouloy, M. & Egly, J. M. ( 2004; ). TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116, 541–550.[CrossRef]
    [Google Scholar]
  306. Lee, H. K., Dunzendorfer, S., Soldau, K. & Tobias, P. S. ( 2006; ). Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24, 153–163.[CrossRef]
    [Google Scholar]
  307. Lee, H. K., Lund, J. M., Ramanathan, B., Mizushima, N. & Iwasaki, A. ( 2007; ). Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315, 1398–1401.[CrossRef]
    [Google Scholar]
  308. Leib, D. A., Machalek, M. A., Williams, B. R., Silverman, R. H. & Virgin, H. W. ( 2000; ). Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A 97, 6097–6101.[CrossRef]
    [Google Scholar]
  309. Lenschow, D. J., Giannakopoulos, N. V., Gunn, L. J., Johnston, C., O'Guin, A. K., Schmidt, R. E., Levine, B. & Virgin, H. W., IV ( 2005; ). Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79, 13974–13983.[CrossRef]
    [Google Scholar]
  310. Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt, R. E. & other authors ( 2007; ). IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104, 1371–1376.[CrossRef]
    [Google Scholar]
  311. Leonard, G. T. & Sen, G. C. ( 1996; ). Effects of adenovirus E1A protein on interferon-signaling. Virology 224, 25–33.[CrossRef]
    [Google Scholar]
  312. Li, Q. & Verma, I. M. ( 2002; ). NF-κB regulation in the immune system. Nat Rev Immunol 2, 725–734.[CrossRef]
    [Google Scholar]
  313. Li, X., Leung, S., Qureshi, S., Darnell, J. E., Jr & Stark, G. R. ( 1996; ). Formation of STAT1–STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-α. J Biol Chem 271, 5790–5794.[CrossRef]
    [Google Scholar]
  314. Li, S., Labrecque, S., Gauzzi, M. C., Cuddihy, A. R., Wong, A. H., Pellegrini, S., Matlashewski, G. J. & Koromilas, A. E. ( 1999; ). The human papillomavirus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α. Oncogene 18, 5727–5737.[CrossRef]
    [Google Scholar]
  315. Li, W., Ross-Smith, N., Proud, C. G. & Belsham, G. J. ( 2001a; ). Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site. FEBS Lett 507, 1–5.[CrossRef]
    [Google Scholar]
  316. Li, Y., Chen, Z. Y., Wang, W., Baker, C. C. & Krug, R. M. ( 2001b; ). The 3′-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA 7, 920–931.[CrossRef]
    [Google Scholar]
  317. Li, C., Ni, C. Z., Havert, M. L., Cabezas, E., He, J., Kaiser, D., Reed, J. C., Satterthwait, A. C., Cheng, G. & Ely, K. R. ( 2002; ). Downstream regulator TANK binds to the CD40 recognition site on TRAF3. Structure 10, 403–411.[CrossRef]
    [Google Scholar]
  318. Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C., Ikeda, M., Ray, S. C., Gale, M., Jr & Lemon, S. M. ( 2005a; ). Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102, 2992–2997.[CrossRef]
    [Google Scholar]
  319. Li, Q., Withoff, S. & Verma, I. M. ( 2005b; ). Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol 26, 318–325.[CrossRef]
    [Google Scholar]
  320. Li, X. D., Sun, L., Seth, R. B., Pineda, G. & Chen, Z. J. ( 2005c; ). Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102, 17717–17722.[CrossRef]
    [Google Scholar]
  321. Li, H., Kobayashi, M., Blonska, M., You, Y. & Lin, X. ( 2006a; ). Ubiquitination of RIP is required for tumor necrosis factor α-induced NF-κB activation. J Biol Chem 281, 13636–13643.[CrossRef]
    [Google Scholar]
  322. Li, S., Min, J. Y., Krug, R. M. & Sen, G. C. ( 2006b; ). Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349, 13–21.[CrossRef]
    [Google Scholar]
  323. Li, Q., Means, R., Lang, S. & Jung, J. U. ( 2007; ). Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol 81, 2117–2127.[CrossRef]
    [Google Scholar]
  324. Lin, R., Heylbroeck, C., Pitha, P. M. & Hiscott, J. ( 1998; ). Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18, 2986–2996.
    [Google Scholar]
  325. Lin, R., Genin, P., Mamane, Y. & Hiscott, J. ( 2000; ). Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 20, 6342–6353.[CrossRef]
    [Google Scholar]
  326. Lin, R., Genin, P., Mamane, Y., Sgarbanti, M., Battistini, A., Harrington, W. J., Jr, Barber, G. N. & Hiscott, J. ( 2001; ). HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 20, 800–811.[CrossRef]
    [Google Scholar]
  327. Lin, R., Noyce, R. S., Collins, S. E., Everett, R. D. & Mossman, K. L. ( 2004a; ). The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 78, 1675–1684.[CrossRef]
    [Google Scholar]
  328. Lin, R. J., Liao, C. L., Lin, E. & Lin, Y. L. ( 2004b; ). Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 78, 9285–9294.[CrossRef]
    [Google Scholar]
  329. Lin, R., Lacoste, J., Nakhaei, P., Sun, Q., Yang, L., Paz, S., Wilkinson, P., Julkunen, I., Vitour, D. & other authors ( 2006a; ). Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKϵ molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 80, 6072–6083.[CrossRef]
    [Google Scholar]
  330. Lin, R. J., Chang, B. L., Yu, H. P., Liao, C. L. & Lin, Y. L. ( 2006b; ). Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol 80, 5908–5918.[CrossRef]
    [Google Scholar]
  331. Lin, W., Kim, S. S., Yeung, E., Kamegaya, Y., Blackard, J. T., Kim, K. A., Holtzman, M. J. & Chung, R. T. ( 2006c; ). Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domain. J Virol 80, 9226–9235.[CrossRef]
    [Google Scholar]
  332. Ling, P. D., Peng, R. S., Nakajima, A., Yu, J. H., Tan, J., Moses, S. M., Yang, W. H., Zhao, B., Kieff, E. & other authors ( 2005; ). Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J 24, 3565–3575.[CrossRef]
    [Google Scholar]
  333. Liptakova, H., Kontsekova, E., Alcami, A., Smith, G. L. & Kontsek, P. ( 1997; ). Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-α1 and IFN-α2. Virology 232, 86–90.[CrossRef]
    [Google Scholar]
  334. Liu, W. J., Chen, H. B., Wang, X. J., Huang, H. & Khromykh, A. A. ( 2004; ). Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 78, 12225–12235.[CrossRef]
    [Google Scholar]
  335. Liu, W. J., Wang, X. J., Mokhonov, V. V., Shi, P. Y., Randall, R. & Khromykh, A. A. ( 2005; ). Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol 79, 1934–1942.[CrossRef]
    [Google Scholar]
  336. Liu, W. J., Wang, X. J., Clark, D. C., Lobigs, M., Hall, R. A. & Khromykh, A. A. ( 2006; ). A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol 80, 2396–2404.[CrossRef]
    [Google Scholar]
  337. Loo, Y. M., Owen, D. M., Li, K., Erickson, A. K., Johnson, C. L., Fish, P. M., Carney, D. S., Wang, T., Ishida, H. & other authors ( 2006; ). Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 103, 6001–6006.[CrossRef]
    [Google Scholar]
  338. Look, D. C., Roswit, W. T., Frick, A. G., Gris-Alevy, Y., Dickhaus, D. M., Walter, M. J. & Holtzman, M. J. ( 1998; ). Direct suppression of Stat1 function during adenoviral infection. Immunity 9, 871–880.[CrossRef]
    [Google Scholar]
  339. Lu, Y., Wambach, M., Katze, M. G. & Krug, R. M. ( 1995; ). Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214, 222–228.[CrossRef]
    [Google Scholar]
  340. Lu, G., Reinert, J. T., Pitha-Rowe, I., Okumura, A., Kellum, M., Knobeloch, K. P., Hassel, B. & Pitha, P. M. ( 2006; ). ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisy-le-grand) 52, 29–41.
    [Google Scholar]
  341. Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A. & Flavell, R. A. ( 2004; ). Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101, 5598–5603.[CrossRef]
    [Google Scholar]
  342. Maher, S. G., Romero-Weaver, A. L., Scarzello, A. J. & Gamero, A. M. ( 2007; ). Interferon: cellular executioner or white knight? Curr Med Chem 14, 1279–1289.[CrossRef]
    [Google Scholar]
  343. Maitra, R. K., McMillan, N. A., Desai, S., McSwiggen, J., Hovanessian, A. G., Sen, G., Williams, B. R. & Silverman, R. H. ( 1994; ). HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204, 823–827.[CrossRef]
    [Google Scholar]
  344. Majumder, S., Zhou, L. Z., Chaturvedi, P., Babcock, G., Aras, S. & Ransohoff, R. M. ( 1998; ). p48/STAT-1α-containing complexes play a predominant role in induction of IFN-γ-inducible protein, 10 kDa (IP-10) by IFN-γ alone or in synergy with TNF-α. J Immunol 161, 4736–4744.
    [Google Scholar]
  345. Malakhov, M. P., Kim, K. I., Malakhova, O. A., Jacobs, B. S., Borden, E. C. & Zhang, D. E. ( 2003; ). High-throughput immunoblotting. Ubiquitin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 278, 16608–16613.[CrossRef]
    [Google Scholar]
  346. Malakhova, O. A., Yan, M., Malakhov, M. P., Yuan, Y., Ritchie, K. J., Kim, K. I., Peterson, L. F., Shuai, K. & Zhang, D. E. ( 2003; ). Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev 17, 455–460.[CrossRef]
    [Google Scholar]
  347. Malathi, K., Dong, B., Gale, M., Jr & Silverman, R. H. ( 2007; ). Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448, 816–819.[CrossRef]
    [Google Scholar]
  348. Malim, M. H. ( 2006; ). Natural resistance to HIV infection: the Vif–APOBEC interaction. C R Biol 329, 871–875.[CrossRef]
    [Google Scholar]
  349. Marcus, P. I. ( 1983; ). Interferon induction by viruses: one molecule of dsRNA as the threshold for interferon induction. Interferon 5, 115–180.
    [Google Scholar]
  350. Marcus, P. I. & Sekellick, M. J. ( 1977; ). Defective interfering particles with covalently linked [+/−]RNA induce interferon. Nature 266, 815–819.[CrossRef]
    [Google Scholar]
  351. Marie, I., Durbin, J. E. & Levy, D. E. ( 1998; ). Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J 17, 6660–6669.[CrossRef]
    [Google Scholar]
  352. Marq, J. B., Brini, A., Kolakofsky, D. & Garcin, D. ( 2007; ). Targeting of the Sendai virus C protein to the plasma membrane via a peptide-only membrane anchor. J Virol 81, 3187–3197.[CrossRef]
    [Google Scholar]
  353. Marques, J. T., Rebouillat, D., Ramana, C. V., Murakami, J., Hill, J. E., Gudkov, A., Silverman, R. H., Stark, G. R. & Williams, B. R. ( 2005; ). Down-regulation of p53 by double-stranded RNA modulates the antiviral response. J Virol 79, 11105–11114.[CrossRef]
    [Google Scholar]
  354. Marrack, P., Kappler, J. & Mitchell, T. ( 1999; ). Type I interferons keep activated T cells alive. J Exp Med 189, 521–530.[CrossRef]
    [Google Scholar]
  355. Martens, S. & Howard, J. ( 2006; ). The interferon-inducible GTPases. Annu Rev Cell Dev Biol 22, 559–589.[CrossRef]
    [Google Scholar]
  356. Martinand, C., Salehzada, T., Silhol, M., Lebleu, B. & Bisbal, C. ( 1998; ). RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. Eur J Biochem 254, 248–255.[CrossRef]
    [Google Scholar]
  357. Martinand, C., Montavon, C., Salehzada, T., Silhol, M., Lebleu, B. & Bisbal, C. ( 1999; ). RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol 73, 290–296.
    [Google Scholar]
  358. Martinez-Costas, J., Gonzalez-Lopez, C., Vakharia, V. N. & Benavente, J. ( 2000; ). Possible involvement of the double-stranded RNA-binding core protein sigmaA in the resistance of avian reovirus to interferon. J Virol 74, 1124–1131.[CrossRef]
    [Google Scholar]
  359. Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K. & Seya, T. ( 2002; ). Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293, 1364–1369.[CrossRef]
    [Google Scholar]
  360. Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kundig, T., Amakawa, R., Kishihara, K. & other authors ( 1993; ). Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75, 83–97.[CrossRef]
    [Google Scholar]
  361. McFadden, G. ( 2005; ). Poxvirus tropism. Nat Rev Microbiol 3, 201–213.[CrossRef]
    [Google Scholar]
  362. Meager, A., Visvalingam, K., Dilger, P., Bryan, D. & Wadhwa, M. ( 2005; ). Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 31, 109–118.[CrossRef]
    [Google Scholar]
  363. Mee, A. P., Dixon, J. A., Hoyland, J. A., Davies, M., Selby, P. L. & Mawer, E. B. ( 1998; ). Detection of canine distemper virus in 100 % of Paget's disease samples by in situ-reverse transcriptase-polymerase chain reaction. Bone 23, 171–175.[CrossRef]
    [Google Scholar]
  364. Melchjorsen, J., Jensen, S. B., Malmgaard, L., Rasmussen, S. B., Weber, F., Bowie, A. G., Matikainen, S. & Paludan, S. R. ( 2005; ). Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol 79, 12944–12951.[CrossRef]
    [Google Scholar]
  365. Melroe, G. T., DeLuca, N. A. & Knipe, D. M. ( 2004; ). Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol 78, 8411–8420.[CrossRef]
    [Google Scholar]
  366. Melroe, G. T., Silva, L., Schaffer, P. A. & Knipe, D. M. ( 2007; ). Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-β induction. Virology 360, 305–321.[CrossRef]
    [Google Scholar]
  367. Mennechet, F. J. & Uze, G. ( 2006; ). Interferon-λ-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 107, 4417–4423.[CrossRef]
    [Google Scholar]
  368. Merika, M. & Thanos, D. ( 2001; ). Enhanceosomes. Curr Opin Genet Dev 11, 205–208.[CrossRef]
    [Google Scholar]
  369. Meylan, E., Burns, K., Hofmann, K., Blancheteau, V., Martinon, F., Kelliher, M. & Tschopp, J. ( 2004; ). RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nat Immunol 5, 503–507.[CrossRef]
    [Google Scholar]
  370. Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R. & Tschopp, J. ( 2005; ). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172.[CrossRef]
    [Google Scholar]
  371. Mibayashi, M., Martinez-Sobrido, L., Loo, Y. M., Cardenas, W. B., Gale, M., Jr & Garcia-Sastre, A. ( 2007; ). Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81, 514–524.[CrossRef]
    [Google Scholar]
  372. Miller, D. M., Rahill, B. M., Boss, J. M., Lairmore, M. D., Durbin, J. E., Waldman, J. W. & Sedmak, D. D. ( 1998; ). Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 187, 675–683.[CrossRef]
    [Google Scholar]
  373. Miller, D. M., Zhang, Y., Rahill, B. M., Waldman, W. J. & Sedmak, D. D. ( 1999; ). Human cytomegalovirus inhibits IFN-α-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 162, 6107–6113.
    [Google Scholar]
  374. Mills, B. G., Singer, F. R., Weiner, L. P., Suffin, S. C., Stabile, E. & Holst, P. ( 1984; ). Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin Orthop Relat Res 183, 303–311.
    [Google Scholar]
  375. Min, J. Y. & Krug, R. M. ( 2006; ). The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103, 7100–7105.[CrossRef]
    [Google Scholar]
  376. Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D. & Martuza, R. L. ( 1995; ). Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med 1, 938–943.[CrossRef]
    [Google Scholar]
  377. Mohr, I. ( 2004; ). Neutralizing innate host defenses to control viral translation in HSV-1 infected cells. Int Rev Immunol 23, 199–220.[CrossRef]
    [Google Scholar]
  378. Morin, P., Braganca, J., Bandu, M. T., Lin, R., Hiscott, J., Doly, J. & Civas, A. ( 2002; ). Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription. J Mol Biol 316, 1009–1022.[CrossRef]
    [Google Scholar]
  379. Mosca, J. D. & Pitha, P. M. ( 1986; ). Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol Cell Biol 6, 2279–2283.
    [Google Scholar]
  380. Mossman, K., Upton, C. & McFadden, G. ( 1995a; ). The myxoma virus-soluble interferon-γ receptor homolog, M-T7, inhibits interferon-γ in a species-specific manner. J Biol Chem 270, 3031–3038.[CrossRef]
    [Google Scholar]
  381. Mossman, K., Upton, C., Buller, R. M. & McFadden, G. ( 1995b; ). Species specificity of ectromelia virus and vaccinia virus interferon-γ binding proteins. Virology 208, 762–769.[CrossRef]
    [Google Scholar]
  382. Mossman, K. L., Macgregor, P. F., Rozmus, J. J., Goryachev, A. B., Edwards, A. M. & Smiley, J. R. ( 2001; ). Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 75, 750–758.[CrossRef]
    [Google Scholar]
  383. Mrkic, B., Pavlovic, J., Rulicke, T., Volpe, P., Buchholz, C. J., Hourcade, D., Atkinson, J. P., Aguzzi, A. & Cattaneo, R. ( 1998; ). Measles virus spread and pathogenesis in genetically modified mice. J Virol 72, 7420–7427.
    [Google Scholar]
  384. Munoz-Fontela, C., Angel Garcia, M., Garcia-Cao, I., Collado, M., Arroyo, J., Esteban, M., Serrano, M. & Rivas, C. ( 2005; ). Resistance to viral infection of super p53 mice. Oncogene 24, 3059–3062.[CrossRef]
    [Google Scholar]
  385. Munoz-Jordan, J. L., Sanchez-Burgos, G. G., Laurent-Rolle, M. & Garcia-Sastre, A. ( 2003; ). Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100, 14333–14338.[CrossRef]
    [Google Scholar]
  386. Munoz-Jordan, J. L., Laurent-Rolle, M., Ashour, J., Martinez-Sobrido, L., Ashok, M., Lipkin, W. I. & Garcia-Sastre, A. ( 2005; ). Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79, 8004–8013.[CrossRef]
    [Google Scholar]
  387. Munz, C. ( 2007; ). Viral evasion of autophagy. Cell Host Microbe 1, 9–11.[CrossRef]
    [Google Scholar]
  388. Murphy, J. A., Duerst, R. J., Smith, T. J. & Morrison, L. A. ( 2003; ). Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 77, 9337–9345.[CrossRef]
    [Google Scholar]
  389. Murray, P. J. ( 2007; ). The JAK-STAT signaling pathway: input and output integration. J Immunol 178, 2623–2629.[CrossRef]
    [Google Scholar]
  390. Nagai, Y. & Kato, A. ( 2004; ). Accessory genes of the Paramyxoviridae, a large family of nonsegmented negative-strand RNA viruses, as a focus of active investigation by reverse genetics. Curr Top Microbiol Immunol 283, 197–248.
    [Google Scholar]
  391. Najarro, P., Traktman, P. & Lewis, J. A. ( 2001; ). Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J Virol 75, 3185–3196.[CrossRef]
    [Google Scholar]
  392. Nanda, S. K. & Baron, M. D. ( 2006; ). Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. J Virol 80, 7555–7568.[CrossRef]
    [Google Scholar]
  393. Navarro, L., Mowen, K., Rodems, S., Weaver, B., Reich, N., Spector, D. & David, M. ( 1998; ). Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol Cell Biol 18, 3796–3802.
    [Google Scholar]
  394. Negishi, H., Fujita, Y., Yanai, H., Sakaguchi, S., Ouyang, X., Shinohara, M., Takayanagi, H., Ohba, Y., Taniguchi, T. & Honda, K. ( 2006; ). Evidence for licensing of IFN-γ-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci U S A 103, 15136–15141.[CrossRef]
    [Google Scholar]
  395. Netterwald, J. R., Jones, T. R., Britt, W. J., Yang, S. J., McCrone, I. P. & Zhu, H. ( 2004; ). Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus. J Virol 78, 6688–6691.[CrossRef]
    [Google Scholar]
  396. Nguyen, K. B., Salazar-Mather, T. P., Dalod, M. Y., Van Deusen, J. B., Wei, X. Q., Liew, F. Y., Caligiuri, M. A., Durbin, J. E. & Biron, C. A. ( 2002; ). Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169, 4279–4287.[CrossRef]
    [Google Scholar]
  397. Nishio, M., Tsurudome, M., Ito, M., Kawano, M., Komada, H. & Ito, Y. ( 2001; ). High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons. J Virol 75, 9165–9176.[CrossRef]
    [Google Scholar]
  398. Nishio, M., Garcin, D., Simonet, V. & Kolakofsky, D. ( 2002; ). The carboxyl segment of the mumps virus V protein associates with Stat proteins in vitro via a tryptophan-rich motif. Virology 300, 92–99.[CrossRef]
    [Google Scholar]
  399. Noah, D. L., Twu, K. Y. & Krug, R. M. ( 2003; ). Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307, 386–395.[CrossRef]
    [Google Scholar]
  400. Nuovo, M. A., Nuovo, G. J., MacConnell, P., Forde, A. & Steiner, G. C. ( 1992; ). In situ analysis of Paget's disease of bone for measles-specific PCR-amplified cDNA. Diagn Mol Pathol 1, 256–265.
    [Google Scholar]
  401. Offermann, M. K. ( 2007; ). Kaposi sarcoma herpesvirus-encoded interferon regulator factors. Curr Top Microbiol Immunol 312, 185–209.
    [Google Scholar]
  402. Oganesyan, G., Saha, S. K., Guo, B., He, J. Q., Shahangian, A., Zarnegar, B., Perry, A. & Cheng, G. ( 2006; ). Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208–211.[CrossRef]
    [Google Scholar]
  403. Ohka, S., Igarashi, H., Nagata, N., Sakai, M., Koike, S., Nochi, T., Kiyono, H. & Nomoto, A. ( 2007; ). Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J Virol 81, 7902–7912.[CrossRef]
    [Google Scholar]
  404. Ohno, S., Ono, N., Takeda, M., Takeuchi, K. & Yanagi, Y. ( 2004; ). Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol 85, 2991–2999.[CrossRef]
    [Google Scholar]
  405. Ohno, S., Ono, N., Seki, F., Takeda, M., Kura, S., Tsuzuki, T. & Yanagi, Y. ( 2007; ). Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol 81, 1650–1659.[CrossRef]
    [Google Scholar]
  406. Okumura, F., Zou, W. & Zhang, D. E. ( 2007; ). ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev 21, 255–260.[CrossRef]
    [Google Scholar]
  407. Olland, A. M., Jane-Valbuena, J., Schiff, L. A., Nibert, M. L. & Harrison, S. C. ( 2001; ). Structure of the reovirus outer capsid and dsRNA-binding protein σ3 at 1.8 Å resolution. EMBO J 20, 979–989.[CrossRef]
    [Google Scholar]
  408. Onoguchi, K., Yoneyama, M., Takemura, A., Akira, S., Taniguchi, T., Namiki, H. & Fujita, T. ( 2007; ). Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282, 7576–7581.
    [Google Scholar]
  409. Ooi, C. G., Walsh, C. A., Gallagher, J. A. & Fraser, W. D. ( 2000; ). Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 27, 417–421.[CrossRef]
    [Google Scholar]
  410. Opitz, B., Rejaibi, A., Dauber, B., Eckhard, J., Vinzing, M., Schmeck, B., Hippenstiel, S., Suttorp, N. & Wolff, T. ( 2006; ). IFNβ induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9, 930–938.
    [Google Scholar]
  411. Orvedahl, A., Alexander, D., Talloczy, Z., Sun, Q., Wei, Y., Zhang, W., Burns, D., Leib, D. A. & Levine, B. ( 2007; ). HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1, 23–35.[CrossRef]
    [Google Scholar]
  412. Oshiumi, H., Sasai, M., Shida, K., Fujita, T., Matsumoto, M. & Seya, T. ( 2003; ). TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-β. J Biol Chem 278, 49751–49762.[CrossRef]
    [Google Scholar]
  413. Paladino, P., Cummings, D. T., Noyce, R. S. & Mossman, K. L. ( 2006; ). The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 177, 8008–8016.[CrossRef]
    [Google Scholar]
  414. Palosaari, H., Parisien, J. P., Rodriguez, J. J., Ulane, C. M. & Horvath, C. M. ( 2003; ). STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol 77, 7635–7644.[CrossRef]
    [Google Scholar]
  415. Pampin, M., Simonin, Y., Blondel, B., Percherancier, Y. & Chelbi-Alix, M. K. ( 2006; ). Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol 80, 8582–8592.[CrossRef]
    [Google Scholar]
  416. Panne, D., Maniatis, T. & Harrison, S. C. ( 2004; ). Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-β enhancer. EMBO J 23, 4384–4393.[CrossRef]
    [Google Scholar]
  417. Panne, D., Maniatis, T. & Harrison, S. C. ( 2007a; ). An atomic model of the interferon-β enhanceosome. Cell 129, 1111–1123.[CrossRef]
    [Google Scholar]
  418. Panne, D., McWhirter, S. M., Maniatis, T. & Harrison, S. C. ( 2007b; ). Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J Biol Chem 282, 22816–22822.[CrossRef]
    [Google Scholar]
  419. Parisien, J. P., Lau, J. F., Rodriguez, J. J., Sullivan, B. M., Moscona, A., Parks, G. D., Lamb, R. A. & Horvath, C. M. ( 2001; ). The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283, 230–239.[CrossRef]
    [Google Scholar]
  420. Parisien, J. P., Lau, J. F. & Horvath, C. M. ( 2002a; ). STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication. J Virol 76, 6435–6441.[CrossRef]
    [Google Scholar]
  421. Parisien, J. P., Lau, J. F., Rodriguez, J. J., Ulane, C. M. & Horvath, C. M. ( 2002b; ). Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J Virol 76, 4190–4198.[CrossRef]
    [Google Scholar]
  422. Park, M. S., Shaw, M. L., Munoz-Jordan, J., Cros, J. F., Nakaya, T., Bouvier, N., Palese, P., Garcia-Sastre, A. & Basler, C. F. ( 2003; ). Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol 77, 1501–1511.[CrossRef]
    [Google Scholar]
  423. Park, G. S., Morris, K. L., Hallett, R. G., Bloom, M. E. & Best, S. M. ( 2007; ). Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain. J Virol 81, 6936–6946.[CrossRef]
    [Google Scholar]
  424. Patel, C. V., Handy, I., Goldsmith, T. & Patel, R. C. ( 2000; ). PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem 275, 37993–37998.[CrossRef]
    [Google Scholar]
  425. Paulus, C., Krauss, S. & Nevels, M. ( 2006; ). A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A 103, 3840–3845.[CrossRef]
    [Google Scholar]
  426. Paun, A. & Pitha, P. M. ( 2007; ). The IRF family, revisited. Biochimie 89, 744–753.[CrossRef]
    [Google Scholar]
  427. Pedersen, I. M., Cheng, G., Wieland, S., Volinia, S., Croce, C. M., Chisari, F. V. & David, M. ( 2007; ). Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919–922.[CrossRef]
    [Google Scholar]
  428. Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T. & Wahl, S. M. ( 2006; ). Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J Exp Med 203, 41–46.[CrossRef]
    [Google Scholar]
  429. Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X. & other authors ( 1999; ). Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 96, 9212–9217.[CrossRef]
    [Google Scholar]
  430. Perry, S. T. & Compton, T. ( 2006; ). Kaposi's sarcoma-associated herpesvirus virions inhibit interferon responses induced by envelope glycoprotein gpK8.1. J Virol 80, 11105–11114.[CrossRef]
    [Google Scholar]
  431. Peters, K. L., Smith, H. L., Stark, G. R. & Sen, G. C. ( 2002; ). IRF-3-dependent, NFκB- and JNK-independent activation of the 561 and IFN-β genes in response to double-stranded RNA. Proc Natl Acad Sci U S A 99, 6322–6327.[CrossRef]
    [Google Scholar]
  432. Petricoin, E. F., III, Ito, S., Williams, B. L., Audet, S., Stancato, L. F., Gamero, A., Clouse, K., Grimley, P., Weiss, A. & other authors ( 1997; ). Antiproliferative action of interferon-α requires components of T-cell-receptor signalling. Nature 390, 629–632.[CrossRef]
    [Google Scholar]
  433. Pichlmair, A., Schulz, O., Tan, C. P., Naslund, T. I., Liljestrom, P., Weber, F. & Reis e Sousa, C. ( 2006; ). RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997–1001.[CrossRef]
    [Google Scholar]
  434. Pitha, P. M. ( 2000; ). Introduction: interferon's connection to cancer. Semin Cancer Biol 10, 69–72.[CrossRef]
    [Google Scholar]
  435. Platanias, L. C. ( 2005; ). Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5, 375–386.[CrossRef]
    [Google Scholar]
  436. Pomerantz, J. L. & Baltimore, D. ( 1999; ). NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18, 6694–6704.[CrossRef]
    [Google Scholar]
  437. Poole, E., He, B., Lamb, R. A., Randall, R. E. & Goodbourn, S. ( 2002; ). The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-β. Virology 303, 33–46.[CrossRef]
    [Google Scholar]
  438. Poppers, J., Mulvey, M., Khoo, D. & Mohr, I. ( 2000; ). Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J Virol 74, 11215–11221.[CrossRef]
    [Google Scholar]
  439. Poppers, J., Mulvey, M., Perez, C., Khoo, D. & Mohr, I. ( 2003; ). Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation. J Virol 77, 228–236.[CrossRef]
    [Google Scholar]
  440. Porter, F. W., Bochkov, Y. A., Albee, A. J., Wiese, C. & Palmenberg, A. C. ( 2006; ). A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc Natl Acad Sci U S A 103, 12417–12422.[CrossRef]
    [Google Scholar]
  441. Powell, P. P., Dixon, L. K. & Parkhouse, R. M. ( 1996; ). An IκB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol 70, 8527–8533.
    [Google Scholar]
  442. Prakash, A., Smith, E., Lee, C. K. & Levy, D. E. ( 2005; ). Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem 280, 18651–18657.[CrossRef]
    [Google Scholar]
  443. Precious, B., Childs, K., Fitzpatrick-Swallow, V., Goodbourn, S. & Randall, R. E. ( 2005a; ). Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol 79, 13434–13441.[CrossRef]
    [Google Scholar]
  444. Precious, B., Young, D. F., Andrejeva, L., Goodbourn, S. & Randall, R. E. ( 2005b; ). In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2. J Gen Virol 86, 151–158.[CrossRef]
    [Google Scholar]
  445. Prentice, E., Jerome, W. G., Yoshimori, T., Mizushima, N. & Denison, M. R. ( 2004; ). Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem 279, 10136–10141.[CrossRef]
    [Google Scholar]
  446. Preston, C. M. & Nicholl, M. J. ( 2006; ). Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol 87, 1113–1121.[CrossRef]
    [Google Scholar]
  447. Preston, C. M., Harman, A. N. & Nicholl, M. J. ( 2001; ). Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 75, 8909–8916.[CrossRef]
    [Google Scholar]
  448. Puehler, F., Weining, K. C., Symons, J. A., Smith, G. L. & Staeheli, P. ( 1998; ). Vaccinia virus-encoded cytokine receptor binds and neutralizes chicken interferon-gamma. Virology 248, 231–240.[CrossRef]
    [Google Scholar]
  449. Qing, J., Liu, C., Choy, L., Wu, R.-Y., Pagano, J. S. & Derynck, R. ( 2004; ). Transforming growth factor β/Smad3 signaling regulates IRF-7 function and transcriptional activation of the beta interferon promoter. Mol Cell Biol 24, 1411–1425.[CrossRef]
    [Google Scholar]
  450. Ralston, S. H., Afzal, M. A., Helfrich, M. H., Fraser, W. D., Gallagher, J. A., Mee, A. & Rima, B. ( 2007; ). Multicentre blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone. J Bone Miner Res 22, 569–577.[CrossRef]
    [Google Scholar]
  451. Ramaswamy, M., Shi, L., Monick, M. M., Hunninghake, G. W. & Look, D. C. ( 2004; ). Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 30, 893–900.[CrossRef]
    [Google Scholar]
  452. Ramaswamy, M., Shi, L., Varga, S. M., Barik, S., Behlke, M. A. & Look, D. C. ( 2006; ). Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344, 328–339.[CrossRef]
    [Google Scholar]
  453. Randall, G., Chen, L., Panis, M., Fischer, A. K., Lindenbach, B. D., Sun, J., Heathcote, J., Rice, C. M., Edwards, A. M. & McGilvray, I. D. ( 2006; ). Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology 131, 1584–1591.[CrossRef]
    [Google Scholar]
  454. Rani, M. R. & Ransohoff, R. M. ( 2005; ). Alternative and accessory pathways in the regulation of IFN-β-mediated gene expression. J Interferon Cytokine Res 25, 788–798.[CrossRef]
    [Google Scholar]
  455. Reddy, S. V., Menaa, C., Singer, F. R., Cundy, T., Cornish, J., Whyte, M. P. & Roodman, G. D. ( 1999; ). Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone. Exp Hematol 27, 1528–1532.[CrossRef]
    [Google Scholar]
  456. Reich, N. C. & Liu, L. ( 2006; ). Tracking STAT nuclear traffic. Nat Rev Immunol 6, 602–612.[CrossRef]
    [Google Scholar]
  457. Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T. & Basler, C. F. ( 2006; ). Ebola virus VP24 binds karyopherin α1 and blocks STAT1 nuclear accumulation. J Virol 80, 5156–5167.[CrossRef]
    [Google Scholar]
  458. Revilla, Y., Callejo, M., Rodriguez, J. M., Culebras, E., Nogal, M. L., Salas, M. L., Vinuela, E. & Fresno, M. ( 1998; ). Inhibition of nuclear factor κB activation by a virus-encoded IκB-like protein. J Biol Chem 273, 5405–5411.[CrossRef]
    [Google Scholar]
  459. Rezaee, S. A., Cunningham, C., Davison, A. J. & Blackbourn, D. J. ( 2006; ). Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol 87, 1781–1804.[CrossRef]
    [Google Scholar]
  460. Richt, J. A., Lekcharoensuk, P., Lager, K. M., Vincent, A. L., Loiacono, C. M., Janke, B. H., Wu, W. H., Yoon, K. J., Webby, R. J. & other authors ( 2006; ). Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J Virol 80, 11009–11018.[CrossRef]
    [Google Scholar]
  461. Rima, B. K., Gassen, U., Helfrich, M. H. & Ralston, S. H. ( 2002; ). The pro and con of measles virus in Paget's disease: con. J Bone Miner Res 17, 2290–2292.[CrossRef]
    [Google Scholar]
  462. Ritchie, K. J., Hahn, C. S., Kim, K. I., Yan, M., Rosario, D., Li, L., de la Torre, J. C. & Zhang, D. E. ( 2004; ). Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 10, 1374–1378.[CrossRef]
    [Google Scholar]
  463. Rivera, J., Abrams, C., Hernaez, B., Alcazar, A., Escribano, J. M., Dixon, L. & Alonso, C. ( 2007; ). The MyD116 African swine fever virus homologue interacts with the catalytic subunit of protein phosphatase 1 and activates its phosphatase activity. J Virol 81, 2923–2929.[CrossRef]
    [Google Scholar]
  464. Rivieccio, M. A., Suh, H. S., Zhao, Y., Zhao, M. L., Chin, K. C., Lee, S. C. & Brosnan, C. F. ( 2006; ). TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol 177, 4735–4741.[CrossRef]
    [Google Scholar]
  465. Rodriguez, J. J. & Horvath, C. M. ( 2004; ). Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling. Viral Immunol 17, 210–219.[CrossRef]
    [Google Scholar]
  466. Rodriguez, J. J., Parisien, J. P. & Horvath, C. M. ( 2002; ). Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 76, 11476–11483.[CrossRef]
    [Google Scholar]
  467. Rodriguez, J. J., Wang, L. F. & Horvath, C. M. ( 2003; ). Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation. J Virol 77, 11842–11845.[CrossRef]
    [Google Scholar]
  468. Ronco, L. V., Karpova, A. Y., Vidal, M. & Howley, P. M. ( 1998; ). Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12, 2061–2072.[CrossRef]
    [Google Scholar]
  469. Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B. G., Schoenemeyer, A., Yamamoto, M., Akira, S. & Fitzgerald, K. A. ( 2005; ). The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J Immunol 175, 5260–5268.[CrossRef]
    [Google Scholar]
  470. Rouille, Y., Helle, F., Delgrange, D., Roingeard, P., Voisset, C., Blanchard, E., Belouzard, S., McKeating, J., Patel, A. H. & other authors ( 2006; ). Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80, 2832–2841.[CrossRef]
    [Google Scholar]
  471. Ruggli, N., Bird, B. H., Liu, L., Bauhofer, O., Tratschin, J. D. & Hofmann, M. A. ( 2005; ). Npro of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-α/β induction. Virology 340, 265–276.[CrossRef]
    [Google Scholar]
  472. Ryzhakov, G. & Randow, F. ( 2007; ). SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J 26, 3180–3190.[CrossRef]
    [Google Scholar]
  473. Saffert, R. T. & Kalejta, R. F. ( 2006; ). Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80, 3863–3871.[CrossRef]
    [Google Scholar]
  474. Saira, K., Zhou, Y. & Jones, C. ( 2007; ). The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity. J Virol 81, 3077–3086.[CrossRef]
    [Google Scholar]
  475. Saito, S., Ogino, T., Miyajima, N., Kato, A. & Kohase, M. ( 2002; ). Dephosphorylation failure of tyrosine-phosphorylated STAT1 in IFN-stimulated Sendai virus C protein-expressing cells. Virology 293, 205–209.[CrossRef]
    [Google Scholar]
  476. Saito, T., Hirai, R., Loo, Y. M., Owen, D., Johnson, C. L., Sinha, S. C., Akira, S., Fujita, T. & Gale, M., Jr ( 2007; ). Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 104, 582–587.[CrossRef]
    [Google Scholar]
  477. Sakuma, R., Mael, A. A. & Ikeda, Y. ( 2007; ). Interferon alpha enhances the TRIM5α-mediated antiviral activities in human and rhesus monkey cells. J Virol 81, 10201–10206.[CrossRef]
    [Google Scholar]
  478. Samuel, C. E. ( 1998; ). Reoviruses and the interferon system. Curr Top Microbiol Immunol 233, 125–145.
    [Google Scholar]
  479. Sarkar, S. N., Peters, K. L., Elco, C. P., Sakamoto, S., Pal, S. & Sen, G. C. ( 2004; ). Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11, 1060–1067.[CrossRef]
    [Google Scholar]
  480. Sarkis, P. T., Ying, S., Xu, R. & Yu, X. F. ( 2006; ). STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-α. J Immunol 177, 4530–4540.[CrossRef]
    [Google Scholar]
  481. Sasai, M., Oshiumi, H., Matsumoto, M., Inoue, N., Fujita, F., Nakanishi, M. & Seya, T. ( 2005; ). NF-κB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. J Immunol 174, 27–30.[CrossRef]
    [Google Scholar]
  482. Sasai, M., Shingai, M., Funami, K., Yoneyama, M., Fujita, T., Matsumoto, M. & Seya, T. ( 2006; ). NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol 177, 8676–8683.[CrossRef]
    [Google Scholar]
  483. Sato, M., Hata, N., Asagiri, M., Nakaya, T., Taniguchi, T. & Tanaka, N. ( 1998; ). Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441, 106–110.[CrossRef]
    [Google Scholar]
  484. Sato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S. & other authors ( 2000; ). Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13, 539–548.[CrossRef]
    [Google Scholar]
  485. Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K. & Akira, S. ( 2003; ). Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171, 4304–4310.[CrossRef]
    [Google Scholar]
  486. Satterly, N., Tsai, P. L., van Deursen, J., Nussenzveig, D. R., Wang, Y., Faria, P. A., Levay, A., Levy, D. E. & Fontoura, B. M. ( 2007; ). Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci U S A 104, 1853–1858.[CrossRef]
    [Google Scholar]
  487. Scheuner, D., Patel, R., Wang, F., Lee, K., Kumar, K., Wu, J., Nilsson, A., Karin, M. & Kaufman, R. J. ( 2006; ). Double-stranded RNA-dependent protein kinase phosphorylation of the α-subunit of eukaryotic translation initiation factor 2 mediates apoptosis. J Biol Chem 281, 21458–21468.[CrossRef]
    [Google Scholar]
  488. Schlender, J., Bossert, B., Buchholz, U. & Conzelmann, K. K. ( 2000; ). Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J Virol 74, 8234–8242.[CrossRef]
    [Google Scholar]
  489. Schlender, J., Hornung, V., Finke, S., Gunthner-Biller, M., Marozin, S., Brzozka, K., Moghim, S., Endres, S., Hartmann, G. & Conzelmann, K. K. ( 2005; ). Inhibition of Toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 79, 5507–5515.[CrossRef]
    [Google Scholar]
  490. Schmid, D., Dengjel, J., Schoor, O., Stevanovic, S. & Munz, C. ( 2006; ). Autophagy in innate and adaptive immunity against intracellular pathogens. J Mol Med 84, 194–202.[CrossRef]
    [Google Scholar]
  491. Schmitz, F., Heit, A., Guggemoos, S., Krug, A., Mages, J., Schiemann, M., Adler, H., Drexler, I., Haas, T. & other authors ( 2007; ). Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-β production in myeloid dendritic cells. Eur J Immunol 37, 315–327.[CrossRef]
    [Google Scholar]
  492. Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A. & Golenbock, D. T. ( 2005; ). The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J Biol Chem 280, 17005–17012.[CrossRef]
    [Google Scholar]
  493. Schulz, O., Diebold, S. S., Chen, M., Naslund, T. I., Nolte, M. A., Alexopoulou, L., Azuma, Y. T., Flavell, R. A., Liljestrom, P. & Reis e Sousa, C. ( 2005; ). Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887–892.[CrossRef]
    [Google Scholar]
  494. Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. ( 2005; ). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122, 669–682.[CrossRef]
    [Google Scholar]
  495. Shabman, R. S., Morrison, T. E., Moore, C., White, L., Suthar, M. S., Hueston, L., Rulli, N., Lidbury, B., Ting, J. P. & other authors ( 2007; ). Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J Virol 81, 237–247.[CrossRef]
    [Google Scholar]
  496. Shaffer, J. A., Bellini, W. J. & Rota, P. A. ( 2003; ). The C protein of measles virus inhibits the type I interferon response. Virology 315, 389–397.[CrossRef]
    [Google Scholar]
  497. Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G. P., Lin, R. & Hiscott, J. ( 2003; ). Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148–1151.[CrossRef]
    [Google Scholar]
  498. Shaw, M. L., Garcia-Sastre, A., Palese, P. & Basler, C. F. ( 2004; ). Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 78, 5633–5641.[CrossRef]
    [Google Scholar]
  499. Shaw, M. L., Cardenas, W. B., Zamarin, D., Palese, P. & Basler, C. F. ( 2005; ). Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and Toll-like receptor 3-triggered signaling pathways. J Virol 79, 6078–6088.[CrossRef]
    [Google Scholar]
  500. Shin, Y. K., Liu, Q., Tikoo, S. K., Babiuk, L. A. & Zhou, Y. ( 2007; ). Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 88, 13–18.[CrossRef]
    [Google Scholar]
  501. Shinohara, M. L., Lu, L., Bu, J., Werneck, M. B., Kobayashi, K. S., Glimcher, L. H. & Cantor, H. ( 2006; ). Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells. Nat Immunol 7, 498–506.[CrossRef]
    [Google Scholar]
  502. Shisler, J. L. & Jin, X. L. ( 2004; ). The vaccinia virus K1L gene product inhibits host NF-κB activation by preventing IκBα degradation. J Virol 78, 3553–3560.[CrossRef]
    [Google Scholar]
  503. Sigurdsson, S., Padyukov, L., Kurreeman, F. A., Liljedahl, U., Wiman, A. C., Alfredsson, L., Toes, R., Ronnelid, J., Klareskog, L. & other authors ( 2007; ). Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 56, 2202–2210.[CrossRef]
    [Google Scholar]
  504. Silverman, R. H. ( 2007; ). Viral encounters with OAS and RNase L during the IFN antiviral response. J Virol in press
    [Google Scholar]
  505. Smiley, J. R. ( 2004; ). Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase? J Virol 78, 1063–1068.[CrossRef]
    [Google Scholar]
  506. Smith, G. L., Symons, J. A. & Alcami, A. ( 1998; ). Poxviruses: interfering with interferon. Semin Virol 8, 409–418.[CrossRef]
    [Google Scholar]
  507. Song, B., Javanbakht, H., Perron, M., Park, D. H., Stremlau, M. & Sodroski, J. ( 2005; ). Retrovirus restriction by TRIM5α variants from Old World and New World primates. J Virol 79, 3930–3937.[CrossRef]
    [Google Scholar]
  508. Soros, V. B. & Greene, W. C. ( 2007; ). APOBEC3G and HIV-1: strike and counterstrike. Curr HIV/AIDS Rep 4, 3–9.[CrossRef]
    [Google Scholar]
  509. Spann, K. M., Tran, K. C. & Collins, P. L. ( 2005; ). Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-κB, and proinflammatory cytokines. J Virol 79, 5353–5362.[CrossRef]
    [Google Scholar]
  510. Spiegel, M., Pichlmair, A., Martinez-Sobrido, L., Cros, J., Garcia-Sastre, A., Haller, O. & Weber, F. ( 2005; ). Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 79, 2079–2086.[CrossRef]
    [Google Scholar]
  511. Spiropoulou, C. F., Albarino, C. G., Ksiazek, T. G. & Rollin, P. E. ( 2007; ). Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81, 2769–2776.[CrossRef]
    [Google Scholar]
  512. Spitkovsky, D., Hehner, S. P., Hofmann, T. G., Moller, A. & Schmitz, M. L. ( 2002; ). The human papillomavirus oncoprotein E7 attenuates NF-κB activation by targeting the IκB kinase complex. J Biol Chem 277, 25576–25582.[CrossRef]
    [Google Scholar]
  513. Srivastava, S. P., Kumar, K. U. & Kaufman, R. J. ( 1998; ). Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J Biol Chem 273, 2416–2423.[CrossRef]
    [Google Scholar]
  514. Stack, J., Haga, I. R., Schroder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L. & Bowie, A. G. ( 2005; ). Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201, 1007–1018.[CrossRef]
    [Google Scholar]
  515. Stancato, L. F., David, M., Carter-Su, C., Larner, A. C. & Pratt, W. B. ( 1996; ). Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J Biol Chem 271, 4134–4137.[CrossRef]
    [Google Scholar]
  516. Stetson, D. B. & Medzhitov, R. ( 2006a; ). Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93–103.[CrossRef]
    [Google Scholar]
  517. Stetson, D. B. & Medzhitov, R. ( 2006b; ). Type I interferons in host defense. Immunity 25, 373–381.[CrossRef]
    [Google Scholar]
  518. Stock, N., Goodbourn, S. & Randall, R. E. ( 2005; ). The anti-interferon mechanisms of paramyxoviruses. In Modulation of Host Gene Expression and Innate Immunity by Viruses, pp. 115–139. Edited by P. Palese. New York: Springer.
  519. Stojdl, D. F., Lichty, B., Knowles, S., Marius, R., Atkins, H., Sonenberg, N. & Bell, J. C. ( 2000; ). Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6, 821–825.[CrossRef]
    [Google Scholar]
  520. Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R., Reynard, J., Poliquin, L. & other authors ( 2003; ). VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4, 263–275.[CrossRef]
    [Google Scholar]
  521. Stracker, T. H., Lee, D. V., Carson, C. T., Araujo, F. D., Ornelles, D. A. & Weitzman, M. D. ( 2005; ). Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J Virol 79, 6664–6673.[CrossRef]
    [Google Scholar]
  522. Strahle, L., Garcin, D. & Kolakofsky, D. ( 2006; ). Sendai virus defective-interfering genomes and the activation of interferon-β. Virology 351, 101–111.[CrossRef]
    [Google Scholar]
  523. Strahle, L., Marq, J.-B., Brini, A., Hausmann, S., Kolakofsky, D. & Garcin, D. ( 2007; ). Activation of the IFNβ promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by the viral C proteins. J Virol in press
    [Google Scholar]
  524. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. & Sodroski, J. ( 2004; ). The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427, 848–853.[CrossRef]
    [Google Scholar]
  525. Sun, S., Zhang, X., Tough, D. F. & Sprent, J. ( 1998; ). Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med 188, 2335–2342.[CrossRef]
    [Google Scholar]
  526. Sun, Q., Sun, L., Liu, H. H., Chen, X., Seth, R. B., Forman, J. & Chen, Z. J. ( 2006; ). The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24, 633–642.[CrossRef]
    [Google Scholar]
  527. Surh, C. D., Boyman, O., Purton, J. F. & Sprent, J. ( 2006; ). Homeostasis of memory T cells. Immunol Rev 211, 154–163.[CrossRef]
    [Google Scholar]
  528. Svitkin, Y. V., Herdy, B., Costa-Mattioli, M., Gingras, A. C., Raught, B. & Sonenberg, N. ( 2005; ). Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol Cell Biol 25, 10556–10565.[CrossRef]
    [Google Scholar]
  529. Symons, J. A., Alcami, A. & Smith, G. L. ( 1995; ). Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81, 551–560.[CrossRef]
    [Google Scholar]
  530. Tabeta, K., Georgel, P., Janssen, E., Du, X., Hoebe, K., Crozat, K., Mudd, S., Shamel, L., Sovath, S. & other authors ( 2004; ). Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 101, 3516–3521.[CrossRef]
    [Google Scholar]
  531. Taima, K., Imaizumi, T., Yamashita, K., Ishikawa, A., Fujita, T., Yoshida, H., Takanashi, S., Okumura, K. & Satoh, K. ( 2006; ). Expression of IP-10/CXCL10 is upregulated by double-stranded RNA in BEAS-2B bronchial epithelial cells. Respiration 73, 360–364.[CrossRef]
    [Google Scholar]
  532. Tait, S. W., Reid, E. B., Greaves, D. R., Wileman, T. E. & Powell, P. P. ( 2000; ). Mechanism of inactivation of NF-κB by a viral homologue of IκBα. Signal-induced release of IκBα results in binding of the viral homologue to NF-κB. J Biol Chem 275, 34656–34664.[CrossRef]
    [Google Scholar]
  533. Takahashi, K., Kawai, T., Kumar, H., Sato, S., Yonehara, S. & Akira, S. ( 2006; ). Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA. J Immunol 176, 4520–4524.[CrossRef]
    [Google Scholar]
  534. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T. & other authors ( 2003; ). Integration of interferon-α/α signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516–523.[CrossRef]
    [Google Scholar]
  535. Takaoka, A., Yanai, H., Kondo, S., Duncan, G., Negishi, H., Mizutani, T., Kano, S., Honda, K., Ohba, Y. & other authors ( 2005; ). Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243–249.[CrossRef]
    [Google Scholar]
  536. Takaoka, A., Wang, Z., Choi, M. K., Yanai, H., Negishi, H., Ban, T., Lu, Y., Miyagishi, M., Kodama, T. & other authors ( 2007; ). DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501–505.[CrossRef]
    [Google Scholar]
  537. Takayanagi, H., Kim, S. & Taniguchi, T. ( 2002; ). Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res 4 (Suppl. 3), S227–S232.[CrossRef]
    [Google Scholar]
  538. Takayanagi, H., Sato, K., Takaoka, A. & Taniguchi, T. ( 2005; ). Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 208, 181–193.[CrossRef]
    [Google Scholar]
  539. Takeuchi, K., Komatsu, T., Yokoo, J., Kato, A., Shioda, T., Nagai, Y. & Gotoh, B. ( 2001; ). Sendai virus C protein physically associates with Stat1. Genes Cells 6, 545–557.[CrossRef]
    [Google Scholar]
  540. Takeuchi, K., Kadota, S. I., Takeda, M., Miyajima, N. & Nagata, K. ( 2003; ). Measles virus V protein blocks interferon (IFN)-α/β but not IFN-γ signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett 545, 177–182.[CrossRef]
    [Google Scholar]
  541. Talloczy, Z., Jiang, W., Virgin, H. W., IV, Leib, D. A., Scheuner, D., Kaufman, R. J., Eskelinen, E. L. & Levine, B. ( 2002; ). Regulation of starvation- and virus-induced autophagy by the eIF2α kinase signaling pathway. Proc Natl Acad Sci U S A 99, 190–195.[CrossRef]
    [Google Scholar]
  542. Talloczy, Z., Virgin, H. W., IV & Levine, B. ( 2006; ). PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2, 24–29.[CrossRef]
    [Google Scholar]
  543. Talon, J., Horvath, C. M., Polley, R., Basler, C. F., Muster, T., Palese, P. & Garcia-Sastre, A. ( 2000a; ). Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74, 7989–7996.[CrossRef]
    [Google Scholar]
  544. Talon, J., Salvatore, M., O'Neill, R. E., Nakaya, Y., Zheng, H., Muster, T., Garcia-Sastre, A. & Palese, P. ( 2000b; ). Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci U S A 97, 4309–4314.[CrossRef]
    [Google Scholar]
  545. Tamura, T., Ueda, S., Yoshida, M., Matsuzaki, M., Mohri, H. & Okubo, T. ( 1996; ). Interferon-γ induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line. Biochem Biophys Res Commun 229, 21–26.[CrossRef]
    [Google Scholar]
  546. Tan, S. L. & Katze, M. G. ( 1998; ). Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res 18, 757–766.[CrossRef]
    [Google Scholar]
  547. Tang, X., Gao, J. S., Guan, Y. J., McLane, K. E., Yuan, Z. L., Ramratnam, B. & Chin, Y. E. ( 2007; ). Acetylation-dependent signal transduction for type I interferon receptor. Cell 131, 93–105.[CrossRef]
    [Google Scholar]
  548. Teng, M. N., Whitehead, S. S., Bermingham, A., St Claire, M., Elkins, W. R., Murphy, B. R. & Collins, P. L. ( 2000; ). Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J Virol 74, 9317–9321.[CrossRef]
    [Google Scholar]
  549. tenOever, B. R., Servant, M. J., Grandvaux, N., Lin, R. & Hiscott, J. ( 2002; ). Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J Virol 76, 3659–3669.[CrossRef]
    [Google Scholar]
  550. tenOever, B. R., Ng, S. L., Chua, M. A., McWhirter, S. M., Garcia-Sastre, A. & Maniatis, T. ( 2007; ). Multiple functions of the IKK-related kinase IKKϵ in interferon-mediated antiviral immunity. Science 315, 1274–1278.[CrossRef]
    [Google Scholar]
  551. Terenzi, F., Pal, S. & Sen, G. C. ( 2005; ). Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54. Virology 340, 116–124.[CrossRef]
    [Google Scholar]
  552. Thomas, D., Blakqori, G., Wagner, V., Banholzer, M., Kessler, N., Elliott, R. M., Haller, O. & Weber, F. ( 2004; ). Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 279, 31471–31477.[CrossRef]
    [Google Scholar]
  553. Toth, A. M., Zhang, P., Das, S., George, C. X. & Samuel, C. E. ( 2006; ). Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog Nucleic Acid Res Mol Biol 81, 369–434.
    [Google Scholar]
  554. Tough, D. F., Borrow, P. & Sprent, J. ( 1996; ). Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947–1950.[CrossRef]
    [Google Scholar]
  555. Towers, G. J. ( 2007; ). The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 4, 40 [CrossRef]
    [Google Scholar]
  556. Twu, J. S. & Schloemer, R. H. ( 1989; ). Transcription of the human beta interferon gene is inhibited by hepatitis B virus. J Virol 63, 3065–3071.
    [Google Scholar]
  557. Uddin, S., Sassano, A., Deb, D. K., Verma, A., Majchrzak, B., Rahman, A., Malik, A. B., Fish, E. N. & Platanias, L. C. ( 2002; ). Protein kinase C-δ (PKC-δ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 277, 14408–14416.[CrossRef]
    [Google Scholar]
  558. Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J. & other authors ( 2005; ). Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J Exp Med 201, 915–923.[CrossRef]
    [Google Scholar]
  559. Ulane, C. M. & Horvath, C. M. ( 2002; ). Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304, 160–166.[CrossRef]
    [Google Scholar]
  560. Ulane, C. M., Rodriguez, J. J., Parisien, J. P. & Horvath, C. M. ( 2003; ). STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J Virol 77, 6385–6393.[CrossRef]
    [Google Scholar]
  561. Ulane, C. M., Kentsis, A., Cruz, C. D., Parisien, J. P., Schneider, K. L. & Horvath, C. M. ( 2005; ). Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain. J Virol 79, 10180–10189.[CrossRef]
    [Google Scholar]
  562. Ullman, A. J., Reich, N. C. & Hearing, P. ( 2007; ). Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol 81, 4744–4752.[CrossRef]
    [Google Scholar]
  563. Unterstab, G., Ludwig, S., Anton, A., Planz, O., Dauber, B., Krappmann, D., Heins, G., Ehrhardt, C. & Wolff, T. ( 2005; ). Viral targeting of the interferon-β-inducing Traf family member-associated NF-κB activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A 102, 13640–13645.[CrossRef]
    [Google Scholar]
  564. Upton, C., Mossman, K. & McFadden, G. ( 1992; ). Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258, 1369–1372.[CrossRef]
    [Google Scholar]
  565. Usacheva, A., Smith, R., Minshall, R., Baida, G., Seng, S., Croze, E. & Colamonici, O. ( 2001; ). The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor. J Biol Chem 276, 22948–22953.[CrossRef]
    [Google Scholar]
  566. Uze, G. & Monneron, D. ( 2007; ). IL-28 and IL-29: newcomers to the interferon family. Biochimie 89, 729–734.[CrossRef]
    [Google Scholar]
  567. Valarcher, J. F., Furze, J., Wyld, S., Cook, R., Conzelmann, K. K. & Taylor, G. ( 2003; ). Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 77, 8426–8439.[CrossRef]
    [Google Scholar]
  568. Valchanova, R. S., Picard-Maureau, M., Budt, M. & Brune, W. ( 2006; ). Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J Virol 80, 10181–10190.[CrossRef]
    [Google Scholar]
  569. van Boxel-Dezaire, A. H., Rani, M. R. & Stark, G. R. ( 2006; ). Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361–372.[CrossRef]
    [Google Scholar]
  570. Van Cleve, W., Amaro-Carambot, E., Surman, S. R., Bekisz, J., Collins, P. L., Zoon, K. C., Murphy, B. R., Skiadopoulos, M. H. & Bartlett, E. J. ( 2006; ). Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology 352, 61–73.[CrossRef]
    [Google Scholar]
  571. van Pesch, V., van Eyll, O. & Michiels, T. ( 2001; ). The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J Virol 75, 7811–7817.[CrossRef]
    [Google Scholar]
  572. Venkataraman, T., Valdes, M., Elsby, R., Kakuta, S., Caceres, G., Saijo, S., Iwakura, Y. & Barber, G. N. ( 2007; ). Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 178, 6444–6455.[CrossRef]
    [Google Scholar]
  573. Vidy, A., El Bougrini, J., Chelbi-Alix, M. K. & Blondel, D. ( 2007; ). The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 81, 4255–4263.[CrossRef]
    [Google Scholar]
  574. Wang, X., Li, M., Zheng, H., Muster, T., Palese, P., Beg, A. A. & Garcia-Sastre, A. ( 2000; ). Influenza A virus NS1 protein prevents activation of NF-κB and induction of alpha/beta interferon. J Virol 74, 11566–11573.[CrossRef]
    [Google Scholar]
  575. Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J. & Chen, Z. J. ( 2001; ). TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346–351.[CrossRef]
    [Google Scholar]
  576. Wang, F., Ma, Y., Barrett, J. W., Gao, X., Loh, J., Barton, E., Virgin, H. W. & McFadden, G. ( 2004; ). Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat Immunol 5, 1266–1274.[CrossRef]
    [Google Scholar]
  577. Wang, X., Hinson, E. R. & Cresswell, P. ( 2007; ). The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2, 96–105.[CrossRef]
    [Google Scholar]
  578. Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M. & Maniatis, T. ( 1998; ). Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol Cell 1, 507–518.[CrossRef]
    [Google Scholar]
  579. Weber, F., Haller, O. & Kochs, G. ( 2000; ). MxA GTPase blocks reporter gene expression of reconstituted Thogoto virus ribonucleoprotein complexes. J Virol 74, 560–563.[CrossRef]
    [Google Scholar]
  580. Weber, F., Bridgen, A., Fazakerley, J. K., Streitenfeld, H., Kessler, N., Randall, R. E. & Elliott, R. M. ( 2002; ). Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76, 7949–7955.[CrossRef]
    [Google Scholar]
  581. Weber, F., Wagner, V., Rasmussen, S. B., Hartmann, R. & Paludan, S. R. ( 2006; ). Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80, 5059–5064.[CrossRef]
    [Google Scholar]
  582. Weihua, X., Ramanujam, S., Lindner, D. J., Kudaravalli, R. D., Freund, R. & Kalvakolanu, D. V. ( 1998; ). The polyoma virus T antigen interferes with interferon-inducible gene expression. Proc Natl Acad Sci U S A 95, 1085–1090.[CrossRef]
    [Google Scholar]
  583. Whitlow, Z. W., Connor, J. H. & Lyles, D. S. ( 2006; ). Preferential translation of vesicular stomatitis virus mRNAs is conferred by transcription from the viral genome. J Virol 80, 11733–11742.[CrossRef]
    [Google Scholar]
  584. Whitten, T. M., Quets, A. T. & Schloemer, R. H. ( 1991; ). Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J Virol 65, 4699–4704.
    [Google Scholar]
  585. Windisch, M. P., Frese, M., Kaul, A., Trippler, M., Lohmann, V. & Bartenschlager, R. ( 2005; ). Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol 79, 13778–13793.[CrossRef]
    [Google Scholar]
  586. Wollmann, G., Robek, M. D. & van den Pol, A. N. ( 2007; ). Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells. J Virol 81, 1479–1491.[CrossRef]
    [Google Scholar]
  587. Wright, P. F., Karron, R. A., Madhi, S. A., Treanor, J. J., King, J. C., O'Shea, A., Ikizler, M. R., Zhu, Y., Collins, P. L. & other authors ( 2006; ). The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J Infect Dis 193, 573–581.[CrossRef]
    [Google Scholar]
  588. Wu, C. J., Conze, D. B., Li, T., Srinivasula, S. M. & Ashwell, J. D. ( 2006; ). Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat Cell Biol 8, 398–406.[CrossRef]
    [Google Scholar]
  589. Wullaert, A., Heyninck, K., Janssens, S. & Beyaert, R. ( 2006; ). Ubiquitin: tool and target for intracellular NF-κB inhibitors. Trends Immunol 27, 533–540.[CrossRef]
    [Google Scholar]
  590. Xu, L. G., Wang, Y. Y., Han, K. J., Li, L. Y., Zhai, Z. & Shu, H. B. ( 2005; ). VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol Cell 19, 727–740.[CrossRef]
    [Google Scholar]
  591. Xu, D., Brumm, K. & Zhang, L. ( 2006; ). The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production. J Biol Chem 281, 9163–9169.[CrossRef]
    [Google Scholar]
  592. Yalamanchili, P., Harris, K., Wimmer, E. & Dasgupta, A. ( 1996; ). Inhibition of basal transcription by poliovirus: a virus-encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro. J Virol 70, 2922–2929.
    [Google Scholar]
  593. Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K. & Akira, S. ( 2002; ). Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J Immunol 169, 6668–6672.[CrossRef]
    [Google Scholar]
  594. Yamamoto, M., Sato, S., Hemmi, H., Uematsu, S., Hoshino, K., Kaisho, T., Takeuchi, O., Takeda, K. & Akira, S. ( 2003a; ). TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4, 1144–1150.[CrossRef]
    [Google Scholar]
  595. Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M. & other authors ( 2003b; ). Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301, 640–643.[CrossRef]
    [Google Scholar]
  596. Yamashita, K., Imaizumi, T., Taima, K., Fujita, T., Ishikawa, A., Yoshida, H., Oyama, C. & Satoh, K. ( 2005; ). Polyinosinic-polycytidylic acid induces the expression of GRO-α in BEAS-2B cells. Inflammation 29, 17–21.[CrossRef]
    [Google Scholar]
  597. Yanai, H., Chen, H. M., Inuzuka, T., Kondo, S., Mak, T. W., Takaoka, A., Honda, K. & Taniguchi, T. ( 2007; ). Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci U S A 104, 3402–3407.[CrossRef]
    [Google Scholar]
  598. Yang, H., Ma, G., Lin, C. H., Orr, M. & Wathelet, M. G. ( 2004; ). Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-β gene promoter. Eur J Biochem 271, 3693–3703.[CrossRef]
    [Google Scholar]
  599. Yap, M. W., Nisole, S., Lynch, C. & Stoye, J. P. ( 2004; ). Trim5α protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101, 10786–10791.[CrossRef]
    [Google Scholar]
  600. Yasuda, K., Richez, C., Maciaszek, J. W., Agrawal, N., Akira, S., Marshak-Rothstein, A. & Rifkin, I. R. ( 2007; ). Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 178, 6876–6885.[CrossRef]
    [Google Scholar]
  601. Yeow, W. S., Au, W. C., Juang, Y. T., Fields, C. D., Dent, C. L., Gewert, D. R. & Pitha, P. M. ( 2000; ). Reconstitution of virus-mediated expression of interferon α genes in human fibroblast cells by ectopic interferon regulatory factor-7. J Biol Chem 275, 6313–6320.[CrossRef]
    [Google Scholar]
  602. Ying, S., Zhang, X., Sarkis, P. T., Xu, R. & Yu, X. ( 2007; ). Cell-specific regulation of APOBEC3F by interferons. Acta Biochim Biophys Sin (Shanghai) 39, 297–304.[CrossRef]
    [Google Scholar]
  603. Yokota, S., Saito, H., Kubota, T., Yokosawa, N., Amano, K. & Fujii, N. ( 2003; ). Measles virus suppresses interferon-α signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-α receptor complex. Virology 306, 135–146.[CrossRef]
    [Google Scholar]
  604. Yokota, S., Yokosawa, N., Okabayashi, T., Suzutani, T., Miura, S., Jimbow, K. & Fujii, N. ( 2004; ). Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J Virol 78, 6282–6286.[CrossRef]
    [Google Scholar]
  605. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S. & Fujita, T. ( 2004; ). The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5, 730–737.[CrossRef]
    [Google Scholar]
  606. Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira, K., Foy, E., Loo, Y. M., Gale, M., Jr & other authors ( 2005; ). Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175, 2851–2858.[CrossRef]
    [Google Scholar]
  607. Young, D. F., Randall, R. E., Hoyle, J. A. & Souberbielle, B. E. ( 1990; ). Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. J Virol 64, 5403–5411.
    [Google Scholar]
  608. Young, D. F., Didcock, L., Goodbourn, S. & Randall, R. E. ( 2000; ). Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269, 383–390.[CrossRef]
    [Google Scholar]
  609. Young, D. F., Chatziandreou, N., He, B., Goodbourn, S., Lamb, R. A. & Randall, R. E. ( 2001; ). Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol 75, 3363–3370.[CrossRef]
    [Google Scholar]
  610. Young, D. F., Andrejeva, L., Livingstone, A., Goodbourn, S., Lamb, R. A., Collins, P. L., Elliott, R. M. & Randall, R. E. ( 2003; ). Virus replication in engineered human cells that do not respond to interferons. J Virol 77, 2174–2181.[CrossRef]
    [Google Scholar]
  611. Yu, Y., Wang, S. E. & Hayward, G. S. ( 2005; ). The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 22, 59–70.[CrossRef]
    [Google Scholar]
  612. Yuan, W. & Krug, R. M. ( 2001; ). Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20, 362–371.[CrossRef]
    [Google Scholar]
  613. Yuan, H., Yoza, B. K. & Lyles, D. S. ( 1998; ). Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID. Virology 251, 383–392.[CrossRef]
    [Google Scholar]
  614. Zahn, R. C., Schelp, I., Utermohlen, O. & von Laer, D. ( 2007; ). A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J Virol 81, 457–464.[CrossRef]
    [Google Scholar]
  615. Zhang, P. & Samuel, C. E. ( 2007; ). Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J Virol 81, 8192–8200.[CrossRef]
    [Google Scholar]
  616. Zhang, J. J., Vinkemeier, U., Gu, W., Chakravarti, D., Horvath, C. M. & Darnell, J. E., Jr ( 1996; ). Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci U S A 93, 15092–15096.[CrossRef]
    [Google Scholar]
  617. Zhang, J., Das, S. C., Kotalik, C., Pattnaik, A. K. & Zhang, L. ( 2004; ). The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes. J Biol Chem 279, 46335–46342.[CrossRef]
    [Google Scholar]
  618. Zhang, Y., Burke, C. W., Ryman, K. D. & Klimstra, W. B. ( 2007; ). Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81, 11246–11255.[CrossRef]
    [Google Scholar]
  619. Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S. & Krug, R. M. ( 2005; ). Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102, 10200–10205.[CrossRef]
    [Google Scholar]
  620. Zhao, T., Yang, L., Sun, Q., Arguello, M., Ballard, D. W., Hiscott, J. & Lin, R. ( 2007; ). The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways. Nat Immunol 8, 592–600.[CrossRef]
    [Google Scholar]
  621. Zhou, Z., Hamming, O. J., Ank, N., Paludan, S. R., Nielsen, A. L. & Hartmann, R. ( 2007; ). Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 81, 7749–7758.[CrossRef]
    [Google Scholar]
  622. Zou, W., Kim, J. H., Handidu, A., Li, X., Kim, K. I., Yan, M., Li, J. & Zhang, D. E. ( 2007; ). Microarray analysis reveals that type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. Biochem Biophys Res Commun 356, 193–199.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83391-0
Loading
/content/journal/jgv/10.1099/vir.0.83391-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error